{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:59:51Z","timestamp":1793372391358,"version":"4.5.0"},"reference-count":278,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82303135"],"award-info":[{"award-number":["82303135"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82103291"],"award-info":[{"award-number":["82103291"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82372760"],"award-info":[{"award-number":["82372760"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"DOI":"10.1186\/s12943-025-02254-5","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T22:20:46Z","timestamp":1740435646000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Role of circular RNAs in cancer therapy resistance"],"prefix":"10.1186","volume":"24","author":[{"given":"Wenjuan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiling","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfei","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linyu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasha","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,25]]},"reference":[{"issue":"3","key":"2254_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"2254_CR2","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41571-021-00514-z","volume":"18","author":"I Soerjomataram","year":"2021","unstructured":"Soerjomataram I, Bray F. Planning for tomorrow: global cancer incidence and the role of prevention 2020\u20132070. Nat Rev Clin Oncol. 2021;18(10):663\u201372. https:\/\/doi.org\/10.1038\/s41571-021-00514-z.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"2254_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12943-017-0598-7","volume":"16","author":"Y Wang","year":"2017","unstructured":"Wang Y, Mo Y, Gong Z, Yang X, Yang M, Zhang S, Xiong F, Xiang B, Zhou M, Liao Q, et al. Circular rnas in human cancer. Mol Cancer. 2017;16(1):25. https:\/\/doi.org\/10.1186\/s12943-017-0598-7.","journal-title":"Mol Cancer"},{"issue":"1","key":"2254_CR4","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41392-024-01808-1","volume":"9","author":"Y Xia","year":"2024","unstructured":"Xia Y, Sun M, Huang H, Jin W. Drug repurposing for cancer therapy. Signal Transduct Target Ther. 2024;9(1):92. https:\/\/doi.org\/10.1038\/s41392-024-01808-1.","journal-title":"Signal Transduct Target Ther"},{"key":"2254_CR5","doi-asserted-by":"publisher","first-page":"101018","DOI":"10.1016\/j.drup.2023.101018","volume":"72","author":"Y Wang","year":"2024","unstructured":"Wang Y, Chen Y, Zhang J, Yang Y, Fleishman JS, Wang Y, Wang J, Chen J, Li Y, Wang H. Cuproptosis: a novel therapeutic target for overcoming cancer drug resistance. Drug Resist Updat. 2024;72:101018. https:\/\/doi.org\/10.1016\/j.drup.2023.101018.","journal-title":"Drug Resist Updat."},{"issue":"3","key":"2254_CR6","doi-asserted-by":"publisher","first-page":"339","DOI":"10.15171\/apb.2017.041","volume":"7","author":"B Mansoori","year":"2017","unstructured":"Mansoori B, Mohammadi A, Davudian S, Shirjang S, Baradaran B. The different mechanisms of cancer drug resistance: a brief review. Adv Pharm Bull. 2017;7(3):339\u201348. https:\/\/doi.org\/10.15171\/apb.2017.041.","journal-title":"Adv Pharm Bull."},{"issue":"3","key":"2254_CR7","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41571-021-00585-y","volume":"19","author":"LS Kristensen","year":"2022","unstructured":"Kristensen LS, Jakobsen T, Hager H, Kjems J. The emerging roles of circrnas in cancer and oncology. Nat Rev Clin Oncol. 2022;19(3):188\u2013206. https:\/\/doi.org\/10.1038\/s41571-021-00585-y.","journal-title":"Nat Rev Clin Oncol"},{"issue":"11","key":"2254_CR8","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1007\/s00109-017-1582-9","volume":"95","author":"PG Maass","year":"2017","unstructured":"Maass PG, Glazar P, Memczak S, Dittmar G, Hollfinger I, Schreyer L, Sauer AV, Toka O, Aiuti A, Luft FC, et al. A map of human circular rnas in clinically relevant tissues. J Mol Med (Berl). 2017;95(11):1179\u201389. https:\/\/doi.org\/10.1007\/s00109-017-1582-9.","journal-title":"J Mol Med (Berl)"},{"issue":"5","key":"2254_CR9","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1016\/j.celrep.2014.10.062","volume":"9","author":"JO Westholm","year":"2014","unstructured":"Westholm JO, Miura P, Olson S, Shenker S, Joseph B, Sanfilippo P, Celniker SE, Graveley BR, Lai EC. Genome-wide analysis of drosophila circular rnas reveals their structural and sequence properties and age-dependent neural accumulation. Cell Rep. 2014;9(5):1966\u201380. https:\/\/doi.org\/10.1016\/j.celrep.2014.10.062.","journal-title":"Cell Rep"},{"issue":"1","key":"2254_CR10","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12943-020-1135-7","volume":"19","author":"M Lei","year":"2020","unstructured":"Lei M, Zheng G, Ning Q, Zheng J, Dong D. Translation and functional roles of circular rnas in human cancer. Mol Cancer. 2020;19(1):30. https:\/\/doi.org\/10.1186\/s12943-020-1135-7.","journal-title":"Mol Cancer"},{"issue":"11","key":"2254_CR11","doi-asserted-by":"publisher","first-page":"3852","DOI":"10.1073\/pnas.73.11.3852","volume":"73","author":"HL Sanger","year":"1976","unstructured":"Sanger HL, Klotz G, Riesner D, Gross HJ, Kleinschmidt AK. Viroids are single-stranded covalently closed circular rna molecules existing as highly base-paired rod-like structures. Proc Natl Acad Sci U S A. 1976;73(11):3852\u20136. https:\/\/doi.org\/10.1073\/pnas.73.11.3852.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2254_CR12","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.celrep.2014.12.019","volume":"10","author":"A Ivanov","year":"2015","unstructured":"Ivanov A, Memczak S, Wyler E, Torti F, Porath HT, Orejuela MR, Piechotta M, Levanon EY, Landthaler M, Dieterich C, et al. Analysis of intron sequences reveals hallmarks of circular rna biogenesis in animals. Cell Rep. 2015;10(2):170\u20137. https:\/\/doi.org\/10.1016\/j.celrep.2014.12.019.","journal-title":"Cell Rep"},{"issue":"1","key":"2254_CR13","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1096\/fasebj.7.1.7678559","volume":"7","author":"C Cocquerelle","year":"1993","unstructured":"Cocquerelle C, Mascrez B, Hetuin D, Bailleul B. Mis-splicing yields circular rna molecules. FASEB J. 1993;7(1):155\u201360. https:\/\/doi.org\/10.1096\/fasebj.7.1.7678559.","journal-title":"FASEB J"},{"issue":"2","key":"2254_CR14","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1261\/rna.035667.112","volume":"19","author":"WR Jeck","year":"2013","unstructured":"Jeck WR, Sorrentino JA, Wang K, Slevin MK, Burd CE, Liu J, Marzluff WF, Sharpless NE. Circular rnas are abundant, conserved, and associated with alu repeats. RNA. 2013;19(2):141\u201357. https:\/\/doi.org\/10.1261\/rna.035667.112.","journal-title":"RNA"},{"issue":"6","key":"2254_CR15","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1093\/bib\/bbw081","volume":"18","author":"S Xia","year":"2017","unstructured":"Xia S, Feng J, Lei L, Hu J, Xia L, Wang J, Xiang Y, Liu L, Zhong S, Han L, et al. Comprehensive characterization of tissue-specific circular rnas in the human and mouse genomes. Brief Bioinform. 2017;18(6):984\u201392. https:\/\/doi.org\/10.1093\/bib\/bbw081.","journal-title":"Brief Bioinform"},{"issue":"6","key":"2254_CR16","doi-asserted-by":"publisher","first-page":"e90859","DOI":"10.1371\/journal.pone.0090859","volume":"9","author":"PL Wang","year":"2014","unstructured":"Wang PL, Bao Y, Yee M, Barrett SP, Hogan GJ, Olsen MN, Dinneny JR, Brown PO, Salzman J. Circular rna is expressed across the eukaryotic tree of life. PLoS One. 2014;9(6):e90859. https:\/\/doi.org\/10.1371\/journal.pone.0090859.","journal-title":"PLoS One"},{"issue":"1","key":"2254_CR17","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41392-022-01102-y","volume":"7","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Liu X, Chen D, Yu J. Radiotherapy combined with immunotherapy: the dawn of cancer treatment. Signal Transduct Target Ther. 2022;7(1):258. https:\/\/doi.org\/10.1038\/s41392-022-01102-y.","journal-title":"Signal Transduct Target Ther"},{"key":"2254_CR18","doi-asserted-by":"publisher","unstructured":"Gao Y, Gao J, Lin F, Wang T, Huo S, Wu J, Zhou Q, Zhang C. Circrnas in tumor radioresistance. Biomolecules. 2022;12(11). https:\/\/doi.org\/10.3390\/biom12111586.","DOI":"10.3390\/biom12111586"},{"issue":"11","key":"2254_CR19","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41576-019-0158-7","volume":"20","author":"LS Kristensen","year":"2019","unstructured":"Kristensen LS, Andersen MS, Stagsted LVW, Ebbesen KK, Hansen TB, Kjems J. The biogenesis, biology and characterization of circular rnas. Nat Rev Genet. 2019;20(11):675\u201391. https:\/\/doi.org\/10.1038\/s41576-019-0158-7.","journal-title":"Nat Rev Genet"},{"issue":"9","key":"2254_CR20","doi-asserted-by":"publisher","first-page":"e1003777","DOI":"10.1371\/journal.pgen.1003777","volume":"9","author":"J Salzman","year":"2013","unstructured":"Salzman J, Chen RE, Olsen MN, Wang PL, Brown PO. Cell-type specific features of circular rna expression. PLoS Genet. 2013;9(9):e1003777. https:\/\/doi.org\/10.1371\/journal.pgen.1003777.","journal-title":"PLoS Genet"},{"issue":"1","key":"2254_CR21","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.molcel.2014.08.019","volume":"56","author":"R Ashwal-Fluss","year":"2014","unstructured":"Ashwal-Fluss R, Meyer M, Pamudurti NR, Ivanov A, Bartok O, Hanan M, Evantal N, Memczak S, Rajewsky N, Kadener S. Circrna biogenesis competes with pre-mrna splicing. Mol Cell. 2014;56(1):55\u201366. https:\/\/doi.org\/10.1016\/j.molcel.2014.08.019.","journal-title":"Mol Cell"},{"issue":"1","key":"2254_CR22","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.cell.2014.09.001","volume":"159","author":"X Zhang","year":"2014","unstructured":"Zhang X, Wang H, Zhang Y, Lu X, Chen L, Yang L. Complementary sequence-mediated exon circularization. Cell. 2014;159(1):134\u201347. https:\/\/doi.org\/10.1016\/j.cell.2014.09.001.","journal-title":"Cell"},{"issue":"3","key":"2254_CR23","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/nrg3662","volume":"15","author":"DL Bentley","year":"2014","unstructured":"Bentley DL. Coupling mrna processing with transcription in time and space. Nat Rev Genet. 2014;15(3):163\u201375. https:\/\/doi.org\/10.1038\/nrg3662.","journal-title":"Nat Rev Genet"},{"issue":"2","key":"2254_CR24","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1080\/15476286.2017.1409931","volume":"15","author":"LS Kristensen","year":"2018","unstructured":"Kristensen LS, Okholm TLH, Veno MT, Kjems J. Circular rnas are abundantly expressed and upregulated during human epidermal stem cell differentiation. RNA Biol. 2018;15(2):280\u201391. https:\/\/doi.org\/10.1080\/15476286.2017.1409931.","journal-title":"RNA Biol"},{"issue":"3","key":"2254_CR25","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.celrep.2016.03.058","volume":"15","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Xue W, Li X, Zhang J, Chen S, Zhang J, Yang L, Chen L. The biogenesis of nascent circular rnas. Cell Rep. 2016;15(3):611\u201324. https:\/\/doi.org\/10.1016\/j.celrep.2016.03.058.","journal-title":"Cell Rep"},{"key":"2254_CR26","doi-asserted-by":"publisher","first-page":"14741","DOI":"10.1038\/ncomms14741","volume":"8","author":"L Errichelli","year":"2017","unstructured":"Errichelli L, Dini Modigliani S, Laneve P, Colantoni A, Legnini I, Capauto D, Rosa A, De Santis R, Scarfo R, Peruzzi G, et al. Fus affects circular rna expression in murine embryonic stem cell-derived motor neurons. Nat Commun. 2017;8:14741. https:\/\/doi.org\/10.1038\/ncomms14741.","journal-title":"Nat Commun"},{"key":"2254_CR27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/978-981-13-1426-1_4","volume":"1087","author":"N Eger","year":"2018","unstructured":"Eger N, Schoppe L, Schuster S, Laufs U, Boeckel J. Circular rna splicing. Adv Exp Med Biol. 2018;1087:41\u201352. https:\/\/doi.org\/10.1007\/978-981-13-1426-1_4.","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"2254_CR28","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.celrep.2014.12.002","volume":"10","author":"S Starke","year":"2015","unstructured":"Starke S, Jost I, Rossbach O, Schneider T, Schreiner S, Hung L, Bindereif A. Exon circularization requires canonical splice signals. Cell Rep. 2015;10(1):103\u201311. https:\/\/doi.org\/10.1016\/j.celrep.2014.12.002.","journal-title":"Cell Rep"},{"issue":"20","key":"2254_CR29","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1101\/gad.270421.115","volume":"29","author":"MC Kramer","year":"2015","unstructured":"Kramer MC, Liang D, Tatomer DC, Gold B, March ZM, Cherry S, Wilusz JE. Combinatorial control of drosophila circular rna expression by intronic repeats, hnrnps, and sr proteins. Genes Dev. 2015;29(20):2168\u201382. https:\/\/doi.org\/10.1101\/gad.270421.115.","journal-title":"Genes Dev"},{"key":"2254_CR30","doi-asserted-by":"publisher","unstructured":"Datta R, Adamska JZ, Bhate A, Li JB. A-to-i rna editing by adar and its therapeutic applications: from viral infections to cancer immunotherapy. Wiley Interdiscip Rev RNA. 2023;e1817. https:\/\/doi.org\/10.1002\/wrna.1817.","DOI":"10.1002\/wrna.1817"},{"issue":"7648","key":"2254_CR31","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nature21715","volume":"544","author":"T Aktas","year":"2017","unstructured":"Aktas T, Avsar Ilik I, Maticzka D, Bhardwaj V, Pessoa Rodrigues C, Mittler G, Manke T, Backofen R, Akhtar A. Dhx9 suppresses rna processing defects originating from the alu invasion of the human genome. Nature. 2017;544(7648):115\u20139. https:\/\/doi.org\/10.1038\/nature21715.","journal-title":"Nature"},{"key":"2254_CR32","doi-asserted-by":"publisher","first-page":"108697","DOI":"10.1016\/j.pharmthera.2024.108697","volume":"261","author":"J Zhang","year":"2024","unstructured":"Zhang J, Xu X, Deng H, Liu L, Xiang Y, Feng J. Overcoming cancer drug-resistance calls for novel strategies targeting abnormal alternative splicing. Pharmacol Ther. 2024;261:108697. https:\/\/doi.org\/10.1016\/j.pharmthera.2024.108697.","journal-title":"Pharmacol Ther"},{"key":"2254_CR33","doi-asserted-by":"publisher","unstructured":"Mehterov N, Kazakova M, Sbirkov Y, Vladimirov B, Belev N, Yaneva G, Todorova K, Hayrabedyan S, Sarafian V. Alternative rna splicing-the trojan horse of cancer cells in chemotherapy. Genes (Basel). 2021;12(7). https:\/\/doi.org\/10.3390\/genes12071085.","DOI":"10.3390\/genes12071085"},{"issue":"2","key":"2254_CR34","doi-asserted-by":"publisher","first-page":"e30733","DOI":"10.1371\/journal.pone.0030733","volume":"7","author":"J Salzman","year":"2012","unstructured":"Salzman J, Gawad C, Wang PL, Lacayo N, Brown PO. Circular rnas are the predominant transcript isoform from hundreds of human genes in diverse cell types. PLoS One. 2012;7(2):e30733. https:\/\/doi.org\/10.1371\/journal.pone.0030733.","journal-title":"PLoS One"},{"key":"2254_CR35","doi-asserted-by":"publisher","unstructured":"Zhu Q, Shah S, Dries R, Cai L, Yuan G. Identification of spatially associated subpopulations by combining scrnaseq and sequential fluorescence in situ hybridization data. Nat Biotechnol. 2018. https:\/\/doi.org\/10.1038\/nbt.4260.","DOI":"10.1038\/nbt.4260"},{"issue":"5","key":"2254_CR36","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.molcel.2015.03.027","volume":"58","author":"A Rybak-Wolf","year":"2015","unstructured":"Rybak-Wolf A, Stottmeister C, Glazar P, Jens M, Pino N, Giusti S, Hanan M, Behm M, Bartok O, Ashwal-Fluss R, et al. Circular rnas in the mammalian brain are highly abundant, conserved, and dynamically expressed. Mol Cell. 2015;58(5):870\u201385. https:\/\/doi.org\/10.1016\/j.molcel.2015.03.027.","journal-title":"Mol Cell"},{"issue":"7441","key":"2254_CR37","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature11993","volume":"495","author":"TB Hansen","year":"2013","unstructured":"Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK, Kjems J. Natural rna circles function as efficient microrna sponges. Nature. 2013;495(7441):384\u20138. https:\/\/doi.org\/10.1038\/nature11993.","journal-title":"Nature"},{"issue":"12","key":"2254_CR38","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1038\/s41374-018-0108-6","volume":"98","author":"M Dahl","year":"2018","unstructured":"Dahl M, Daugaard I, Andersen MS, Hansen TB, Gronbaek K, Kjems J, Kristensen LS. Enzyme-free digital counting of endogenous circular rna molecules in b-cell malignancies. Lab Invest. 2018;98(12):1657\u201369. https:\/\/doi.org\/10.1038\/s41374-018-0108-6.","journal-title":"Lab Invest"},{"issue":"1","key":"2254_CR39","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00109-017-1600-y","volume":"96","author":"T Li","year":"2018","unstructured":"Li T, Shao Y, Fu L, Xie Y, Zhu L, Sun W, Yu R, Xiao B, Guo J. Plasma circular rna profiling of patients with gastric cancer and their droplet digital rt-pcr detection. J Mol Med (Berl). 2018;96(1):85\u201396. https:\/\/doi.org\/10.1007\/s00109-017-1600-y.","journal-title":"J Mol Med (Berl)"},{"issue":"9","key":"2254_CR40","doi-asserted-by":"publisher","first-page":"e184751","DOI":"10.1371\/journal.pone.0184751","volume":"12","author":"Y Maheshwari","year":"2017","unstructured":"Maheshwari Y, Selvaraj V, Hajeri S, Yokomi R. Application of droplet digital pcr for quantitative detection of spiroplasma citri in comparison with real time pcr. PLoS One. 2017;12(9):e184751. https:\/\/doi.org\/10.1371\/journal.pone.0184751.","journal-title":"PLoS One"},{"issue":"6","key":"2254_CR41","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41568-024-00694-7","volume":"24","author":"R Perez-Lopez","year":"2024","unstructured":"Perez-Lopez R, Ghaffari Laleh N, Mahmood F, Kather JN. A guide to artificial intelligence for cancer researchers. Nat Rev Cancer. 2024;24(6):427\u201341. https:\/\/doi.org\/10.1038\/s41568-024-00694-7.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"2254_CR42","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41392-022-00994-0","volume":"7","author":"Y You","year":"2022","unstructured":"You Y, Lai X, Pan Y, Zheng H, Vera J, Liu S, Deng S, Zhang L. Artificial intelligence in cancer target identification and drug discovery. Signal Transduct Target Ther. 2022;7(1):156. https:\/\/doi.org\/10.1038\/s41392-022-00994-0.","journal-title":"Signal Transduct Target Ther"},{"key":"2254_CR43","doi-asserted-by":"publisher","unstructured":"Chen Y, Wang J, Wang C, Liu M, Zou Q. Deep learning models for disease-associated circrna prediction: a review. Brief Bioinform. 2022;23(6). https:\/\/doi.org\/10.1093\/bib\/bbac364.","DOI":"10.1093\/bib\/bbac364"},{"issue":"5","key":"2254_CR44","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.molcel.2017.10.034","volume":"68","author":"D Liang","year":"2017","unstructured":"Liang D, Tatomer DC, Luo Z, Wu H, Yang L, Chen L, Cherry S, Wilusz JE. The output of protein-coding genes shifts to circular rnas when the pre-mrna processing machinery is limiting. Mol Cell. 2017;68(5):940\u201354. https:\/\/doi.org\/10.1016\/j.molcel.2017.10.034.","journal-title":"Mol Cell"},{"issue":"49","key":"2254_CR45","doi-asserted-by":"publisher","first-page":"29208","DOI":"10.18632\/oncotarget.25673","volume":"9","author":"HJ Ferreira","year":"2018","unstructured":"Ferreira HJ, Davalos V, de Moura MC, Soler M, Perez-Salvia M, Bueno-Costa A, Setien F, Moran S, Villanueva A, Esteller M. Circular rna cpg island hypermethylation-associated silencing in human cancer. Oncotarget. 2018;9(49):29208\u201319. https:\/\/doi.org\/10.18632\/oncotarget.25673.","journal-title":"Oncotarget"},{"issue":"1","key":"2254_CR46","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s13059-018-1594-y","volume":"19","author":"N Chen","year":"2018","unstructured":"Chen N, Zhao G, Yan X, Lv Z, Yin H, Zhang S, Song W, Li X, Li L, Du Z, et al. A novel fli1 exonic circular rna promotes metastasis in breast cancer by coordinately regulating tet1 and dnmt1. Genome Biol. 2018;19(1):218. https:\/\/doi.org\/10.1186\/s13059-018-1594-y.","journal-title":"Genome Biol"},{"issue":"6047","key":"2254_CR47","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1126\/science.1210944","volume":"333","author":"Y He","year":"2011","unstructured":"He Y, Li B, Li Z, Liu P, Wang Y, Tang Q, Ding J, Jia Y, Chen Z, Li L, et al. Tet-mediated formation of 5-carboxylcytosine and its excision by tdg in mammalian dna. Science. 2011;333(6047):1303\u20137. https:\/\/doi.org\/10.1126\/science.1210944.","journal-title":"Science"},{"issue":"5","key":"2254_CR48","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1007\/s10528-021-10181-5","volume":"60","author":"J Liu","year":"2022","unstructured":"Liu J, Fu Z. Identification of a novel circ_0010235\/mir-1249-3p\/hoxa13 axis in lung adenocarcinoma. Biochem Genet. 2022;60(5):1657\u201375. https:\/\/doi.org\/10.1007\/s10528-021-10181-5.","journal-title":"Biochem Genet"},{"issue":"20","key":"2254_CR49","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1111\/1759-7714.14941","volume":"14","author":"L Wang","year":"2023","unstructured":"Wang L, Wang D, Xu Z, Qiu Y, Chen G, Tan F. Circ_0010235 confers cisplatin resistance in lung cancer by upregulating e2f7 through absorbing mir-379-5p. Thorac Cancer. 2023;14(20):1946\u201357. https:\/\/doi.org\/10.1111\/1759-7714.14941.","journal-title":"Thorac Cancer"},{"key":"2254_CR50","doi-asserted-by":"publisher","first-page":"102896","DOI":"10.1016\/j.redox.2023.102896","volume":"67","author":"S Wang","year":"2023","unstructured":"Wang S, Wang Y, Li Q, Li X, Feng X, Zeng K. The novel beta-trcp protein isoform hidden in circular rna confers trastuzumab resistance in her2-positive breast cancer. Redox Biol. 2023;67:102896. https:\/\/doi.org\/10.1016\/j.redox.2023.102896.","journal-title":"Redox Biol"},{"issue":"1","key":"2254_CR51","doi-asserted-by":"publisher","first-page":"20230678","DOI":"10.1515\/med-2023-0678","volume":"18","author":"X Wang","year":"2023","unstructured":"Wang X, Zheng D, Wang C, Chen W. Knockdown of circ_0005615 enhances the radiosensitivity of colorectal cancer by regulating the mir-665\/notch1 axis. Open Med (Wars). 2023;18(1):20230678. https:\/\/doi.org\/10.1515\/med-2023-0678.","journal-title":"Open Med (Wars)"},{"key":"2254_CR52","doi-asserted-by":"publisher","first-page":"215810","DOI":"10.1016\/j.canlet.2022.215810","volume":"544","author":"J Li","year":"2022","unstructured":"Li J, Zhang Q, Jiang D, Shao J, Li W, Wang C. Circrnas in lung cancer- role and clinical application. Cancer Lett. 2022;544:215810. https:\/\/doi.org\/10.1016\/j.canlet.2022.215810.","journal-title":"Cancer Lett"},{"issue":"10","key":"2254_CR53","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1097\/CAD.0000000000001388","volume":"33","author":"Y Li","year":"2022","unstructured":"Li Y, Ma Z, Luo M, Liang R. Blocking circ_0010235 suppresses acquired paclitaxel resistance of non-small cell lung cancer by sponging mir-512-5p to modulate fam83f expression. Anticancer Drugs. 2022;33(10):1024\u201334. https:\/\/doi.org\/10.1097\/CAD.0000000000001388.","journal-title":"Anticancer Drugs"},{"issue":"2","key":"2254_CR54","doi-asserted-by":"publisher","first-page":"110294","DOI":"10.1016\/j.ygeno.2022.110294","volume":"114","author":"Y Li","year":"2022","unstructured":"Li Y, Yang X, Xiong X. Circ_0004015 silencing represses cisplatin chemoresistance and tumor progression by reducing klf8 in a mir-198-dependent manner in non-small cell lung cancer. Genomics. 2022;114(2):110294. https:\/\/doi.org\/10.1016\/j.ygeno.2022.110294.","journal-title":"Genomics"},{"issue":"14","key":"2254_CR55","doi-asserted-by":"publisher","first-page":"6422","DOI":"10.7150\/thno.77350","volume":"12","author":"H Li","year":"2022","unstructured":"Li H, Peng K, Yang K, Ma W, Qi S, Yu X, He J, Lin X, Yu G. Circular rna cancer vaccines drive immunity in hard-to-treat malignancies. Theranostics. 2022;12(14):6422\u201336. https:\/\/doi.org\/10.7150\/thno.77350.","journal-title":"Theranostics"},{"issue":"22","key":"2254_CR56","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1111\/1759-7714.14993","volume":"14","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Mi Y, He C. 2-methoxyestradiol restrains non-small cell lung cancer tumorigenesis through regulating circ_0010235\/mir-34a-5p\/nfat5 axis. Thorac Cancer. 2023;14(22):2105\u201315. https:\/\/doi.org\/10.1111\/1759-7714.14993.","journal-title":"Thorac Cancer"},{"issue":"1","key":"2254_CR57","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41419-022-05536-8","volume":"14","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Zheng Y, Liu J, Tang X, Wang Y, Li X, Li H, Zhou X, Tang S, Tang Y, et al. Circifngr2 enhances proliferation and migration of crc and induces cetuximab resistance by indirectly targeting kras via sponging to mir-30b. Cell Death Dis. 2023;14(1):24. https:\/\/doi.org\/10.1038\/s41419-022-05536-8.","journal-title":"Cell Death Dis"},{"issue":"1","key":"2254_CR58","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1080\/07853890.2021.1925736","volume":"53","author":"Y Zhu","year":"2021","unstructured":"Zhu Y, Ma C, Lv A, Kou C. Circular rna circ_0010235 sponges mir-338-3p to play oncogenic role in proliferation, migration and invasion of non-small-cell lung cancer cells through modulating kif2a. Ann Med. 2021;53(1):693\u2013706. https:\/\/doi.org\/10.1080\/07853890.2021.1925736.","journal-title":"Ann Med"},{"issue":"1","key":"2254_CR59","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1186\/s12935-021-02088-3","volume":"21","author":"M Zhu","year":"2021","unstructured":"Zhu M, Wang Y, Wang F, Li L, Qiu X. Circfbxl5 promotes the 5-fu resistance of breast cancer via modulating mir-216b\/hmga2 axis. Cancer Cell Int. 2021;21(1):384. https:\/\/doi.org\/10.1186\/s12935-021-02088-3.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"2254_CR60","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13045-018-0557-9","volume":"11","author":"NA Joseph","year":"2018","unstructured":"Joseph NA, Chiou S, Lung Z, Yang C, Lin T, Chang H, Sun HS, Gupta SK, Yen L, Wang S, et al. The role of hgf-met pathway and ccdc66 cirrna expression in egfr resistance and epithelial-to-mesenchymal transition of lung adenocarcinoma cells. J Hematol Oncol. 2018;11(1):74. https:\/\/doi.org\/10.1186\/s13045-018-0557-9.","journal-title":"J Hematol Oncol"},{"key":"2254_CR61","doi-asserted-by":"publisher","first-page":"5307641","DOI":"10.1155\/2020\/5307641","volume":"2020","author":"W Hong","year":"2020","unstructured":"Hong W, Yu S, Zhuang Y, Zhang Q, Wang J, Gao X. Srcin1 regulated by circccdc66\/mir-211 is upregulated and promotes cell proliferation in non-small-cell lung cancer. Biomed Res Int. 2020;2020:5307641. https:\/\/doi.org\/10.1155\/2020\/5307641.","journal-title":"Biomed Res Int."},{"key":"2254_CR62","doi-asserted-by":"publisher","first-page":"6075902","DOI":"10.1155\/2020\/6075902","volume":"2020","author":"W Hong","year":"2020","unstructured":"Hong W, Zhang Y, Ding J, Yang Q, Xie H, Gao X. Circhipk3 acts as competing endogenous rna and promotes non-small-cell lung cancer progression through the mir-107\/bdnf signaling pathway. Biomed Res Int. 2020;2020:6075902. https:\/\/doi.org\/10.1155\/2020\/6075902.","journal-title":"Biomed Res Int"},{"issue":"1","key":"2254_CR63","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13046-020-01648-1","volume":"39","author":"W Hong","year":"2020","unstructured":"Hong W, Xue M, Jiang J, Zhang Y, Gao X. Circular rna circ-cpa4\/ let-7 mirna\/pd-l1 axis regulates cell growth, stemness, drug resistance and immune evasion in non-small cell lung cancer (nsclc). J Exp Clin Cancer Res. 2020;39(1):149. https:\/\/doi.org\/10.1186\/s13046-020-01648-1.","journal-title":"J Exp Clin Cancer Res"},{"key":"2254_CR64","doi-asserted-by":"publisher","first-page":"110019","DOI":"10.1016\/j.biopha.2020.110019","volume":"126","author":"Y Wang","year":"2020","unstructured":"Wang Y, Zhao W, Zhang S. Stat3-induced upregulation of circccdc66 facilitates the progression of non-small cell lung cancer by targeting mir-33a-5p\/kpna4 axis. Biomed Pharmacother. 2020;126:110019. https:\/\/doi.org\/10.1016\/j.biopha.2020.110019.","journal-title":"Biomed Pharmacother."},{"key":"2254_CR65","doi-asserted-by":"publisher","first-page":"12853","DOI":"10.2147\/CMAR.S273484","volume":"12","author":"G Wang","year":"2020","unstructured":"Wang G, Li Y, Zhu H, Huo G, Bai J, Gao Z. Circ-prkdc facilitates the progression of colorectal cancer through mir-198\/ddr1 regulatory axis. Cancer Manag Res. 2020;12:12853\u201365. https:\/\/doi.org\/10.2147\/CMAR.S273484.","journal-title":"Cancer Manag Res."},{"issue":"3","key":"2254_CR66","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/1878-0261.12629","volume":"14","author":"X Wang","year":"2020","unstructured":"Wang X, Zhang H, Yang H, Bai M, Ning T, Deng T, Liu R, Fan Q, Zhu K, Li J, et al. Exosome-delivered circrna promotes glycolysis to induce chemoresistance through the mir-122-pkm2 axis in colorectal cancer. Mol Oncol. 2020;14(3):539\u201355. https:\/\/doi.org\/10.1002\/1878-0261.12629.","journal-title":"Mol Oncol"},{"key":"2254_CR67","doi-asserted-by":"publisher","first-page":"850","DOI":"10.3389\/fonc.2020.00850","volume":"10","author":"Q Wang","year":"2020","unstructured":"Wang Q, Shi L, Shi K, Yuan B, Cao G, Kong C, Fu J, Man Z, Li X, Zhang X, et al. Circcspp1 functions as a cerna to promote colorectal carcinoma cell emt and liver metastasis by upregulating col1a1. Front Oncol. 2020;10:850. https:\/\/doi.org\/10.3389\/fonc.2020.00850.","journal-title":"Front Oncol"},{"issue":"1","key":"2254_CR68","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12943-023-01811-0","volume":"22","author":"K Li","year":"2023","unstructured":"Li K, Peng Z, Wang R, Li X, Du N, Liu D, Zhang J, Zhang Y, Ma L, Sun Y, et al. Enhancement of tki sensitivity in lung adenocarcinoma through m6a-dependent translational repression of wnt signaling by circ-fbxw7. Mol Cancer. 2023;22(1):103. https:\/\/doi.org\/10.1186\/s12943-023-01811-0.","journal-title":"Mol Cancer"},{"issue":"7","key":"2254_CR69","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/s41419-023-06006-5","volume":"14","author":"Z Li","year":"2023","unstructured":"Li Z, Li Y, Han D, Wang X, Li C, Chen T, Li W, Liang Y, Luo D, Chen B, et al. Circrna-sfmbt2 orchestrates eralpha activation to drive tamoxifen resistance in breast cancer cells. Cell Death Dis. 2023;14(7):482. https:\/\/doi.org\/10.1038\/s41419-023-06006-5.","journal-title":"Cell Death Dis"},{"issue":"1","key":"2254_CR70","doi-asserted-by":"publisher","first-page":"20220604","DOI":"10.1515\/med-2022-0604","volume":"18","author":"W Li","year":"2023","unstructured":"Li W, Wei W, Hu D, Tang R, Hu Z. Circrna itga7 restrains growth and enhances radiosensitivity by up-regulating smad4 in colorectal carcinoma. Open Med (Wars). 2023;18(1):20220604. https:\/\/doi.org\/10.1515\/med-2022-0604.","journal-title":"Open Med (Wars)"},{"issue":"4","key":"2254_CR71","doi-asserted-by":"publisher","first-page":"255","DOI":"10.4274\/balkanmedj.galenos.2022.2022-2-50","volume":"39","author":"H Zhu","year":"2022","unstructured":"Zhu H, Yang W, Cheng Q, Yang S. Circ_0010235 regulates hoxa10 expression to promote malignant phenotypes and radioresistance in non-small cell lung cancer cells via decoying mir-588. Balkan Med J. 2022;39(4):255\u201366. https:\/\/doi.org\/10.4274\/balkanmedj.galenos.2022.2022-2-50.","journal-title":"Balkan Med J"},{"key":"2254_CR72","doi-asserted-by":"publisher","first-page":"8699359","DOI":"10.1155\/2022\/8699359","volume":"2022","author":"S Zhu","year":"2022","unstructured":"Zhu S, Zhang Z, Gu L, Rao D, Tang X, Sang C, Xia Y, Si M, Shi H, Li J, et al. Circfbxw7 inhibits proliferation, migration, and invasion of nonsmall cell lung cancer cells by regulating mir-492. J Oncol. 2022;2022:8699359. https:\/\/doi.org\/10.1155\/2022\/8699359.","journal-title":"J Oncol."},{"issue":"1","key":"2254_CR73","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12943-018-0889-7","volume":"17","author":"L Wang","year":"2018","unstructured":"Wang L, Tong X, Zhou Z, Wang S, Lei Z, Zhang T, Liu Z, Zeng Y, Li C, Zhao J, et al. Circular rna hsa_circ_0008305 (circptk2) inhibits tgf-beta-induced epithelial-mesenchymal transition and metastasis by controlling tif1gamma in non-small cell lung cancer. Mol Cancer. 2018;17(1):140. https:\/\/doi.org\/10.1186\/s12943-018-0889-7.","journal-title":"Mol Cancer"},{"issue":"2","key":"2254_CR74","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1080\/21655979.2021.2024321","volume":"13","author":"Y Wang","year":"2022","unstructured":"Wang Y, Wu Y, Xie S. Circptk2 inhibits cell cisplatin (cddp) resistance by targeting mir-942\/trim16 axis in non-small cell lung cancer (nsclc). Bioengineered. 2022;13(2):3651\u201364. https:\/\/doi.org\/10.1080\/21655979.2021.2024321.","journal-title":"Bioengineered"},{"issue":"1","key":"2254_CR75","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13045-022-01345-w","volume":"15","author":"X Wang","year":"2022","unstructured":"Wang X, Chen T, Li C, Li W, Zhou X, Li Y, Luo D, Zhang N, Chen B, Wang L, et al. Circrna-creit inhibits stress granule assembly and overcomes doxorubicin resistance in tnbc by destabilizing pkr. J Hematol Oncol. 2022;15(1):122. https:\/\/doi.org\/10.1186\/s13045-022-01345-w.","journal-title":"J Hematol Oncol"},{"issue":"7","key":"2254_CR76","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1002\/tox.23509","volume":"37","author":"S Wang","year":"2022","unstructured":"Wang S, Wang Y, Li Q, Li X, Feng X. A novel circular rna confers trastuzumab resistance in human epidermal growth factor receptor 2-positive breast cancer through regulating ferroptosis. Environ Toxicol. 2022;37(7):1597\u2013607. https:\/\/doi.org\/10.1002\/tox.23509.","journal-title":"Environ Toxicol"},{"issue":"1","key":"2254_CR77","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12967-022-03240-x","volume":"20","author":"J Wang","year":"2022","unstructured":"Wang J, Zhou L, Chen B, Yu Z, Zhang J, Zhang Z, Hu C, Bai Y, Ruan X, Wang S, et al. Circular rna circcspp1 promotes the occurrence and development of colon cancer by sponging mir-431 and regulating rock1 and zeb1. J Transl Med. 2022;20(1):58. https:\/\/doi.org\/10.1186\/s12967-022-03240-x.","journal-title":"J Transl Med"},{"issue":"1","key":"2254_CR78","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s13046-022-02432-z","volume":"41","author":"X Wang","year":"2022","unstructured":"Wang X, Zhang J, Cao G, Hua J, Shan G, Lin W. Emerging roles of circular rnas in gastric cancer metastasis and drug resistance. J Exp Clin Cancer Res. 2022;41(1):218. https:\/\/doi.org\/10.1186\/s13046-022-02432-z.","journal-title":"J Exp Clin Cancer Res"},{"key":"2254_CR79","doi-asserted-by":"publisher","first-page":"109828","DOI":"10.1016\/j.biopha.2020.109828","volume":"124","author":"F Zheng","year":"2020","unstructured":"Zheng F, Xu R. Circpvt1 contributes to chemotherapy resistance of lung adenocarcinoma through mir-145\u20135p\/abcc1 axis. Biomed Pharmacother. 2020;124:109828. https:\/\/doi.org\/10.1016\/j.biopha.2020.109828.","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"2254_CR80","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1177\/0300891620941940","volume":"107","author":"H Lu","year":"2021","unstructured":"Lu H, Xie X, Chen Q, Cai S, Liu S, Bao C, Luo J, Kong J. Clinical significance of circpvt1 in patients with non-small cell lung cancer who received cisplatin combined with gemcitabine chemotherapy. Tumori. 2021;107(3):204\u20138. https:\/\/doi.org\/10.1177\/0300891620941940.","journal-title":"Tumori"},{"key":"2254_CR81","doi-asserted-by":"publisher","unstructured":"Cao L, Zhou X, Ding X, Gao D. Knockdown of circ\u2011pvt1 inhibits the progression of lung adenocarcinoma and enhances the sensitivity to cisplatin via the mir\u2011429\/foxk1 signaling axis. Mol Med Rep. 2021;24(4). https:\/\/doi.org\/10.3892\/mmr.2021.12323.","DOI":"10.3892\/mmr.2021.12323"},{"issue":"13","key":"2254_CR82","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1080\/15384101.2020.1761617","volume":"19","author":"D Ma","year":"2020","unstructured":"Ma D, Qin Y, Huang C, Chen Y, Han Z, Zhou X, Liu H. Circular rna abcb10 promotes non-small cell lung cancer progression by increasing e2f5 expression through sponging mir-584-5p. Cell Cycle. 2020;19(13):1611\u201320. https:\/\/doi.org\/10.1080\/15384101.2020.1761617.","journal-title":"Cell Cycle"},{"issue":"11","key":"2254_CR83","doi-asserted-by":"publisher","first-page":"6157","DOI":"10.26355\/eurrev_202006_21511","volume":"24","author":"T Hu","year":"2020","unstructured":"Hu T, Zhu Q, Duan Q, Jin X, Wu R. Circabcb10 promotes the proliferation and migration of lung cancer cells through down-regulating microrna-217 expression. Eur Rev Med Pharmacol Sci. 2020;24(11):6157\u201365. https:\/\/doi.org\/10.26355\/eurrev_202006_21511.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"3","key":"2254_CR84","doi-asserted-by":"publisher","first-page":"3765","DOI":"10.1002\/jcb.27657","volume":"120","author":"X Tian","year":"2019","unstructured":"Tian X, Zhang L, Jiao Y, Chen J, Shan Y, Yang W. Circabcb10 promotes nonsmall cell lung cancer cell proliferation and migration by regulating the mir-1252\/foxr2 axis. J Cell Biochem. 2019;120(3):3765\u201372. https:\/\/doi.org\/10.1002\/jcb.27657.","journal-title":"J Cell Biochem"},{"issue":"1","key":"2254_CR85","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12890-019-1035-z","volume":"20","author":"Z Wu","year":"2020","unstructured":"Wu Z, Gong Q, Yu Y, Zhu J, Li W. Knockdown of circ-abcb10 promotes sensitivity of lung cancer cells to cisplatin via mir-556-3p\/ak4 axis. BMC Pulm Med. 2020;20(1):10. https:\/\/doi.org\/10.1186\/s12890-019-1035-z.","journal-title":"BMC Pulm Med"},{"issue":"12","key":"2254_CR86","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1002\/cbin.11449","volume":"44","author":"J Pang","year":"2020","unstructured":"Pang J, Ye L, Zhao D, Zhao D, Chen Q. Circular rna prmt5 confers cisplatin-resistance via mir-4458\/rev3l axis in non-small-cell lung cancer. Cell Biol Int. 2020;44(12):2416\u201326. https:\/\/doi.org\/10.1002\/cbin.11449.","journal-title":"Cell Biol Int"},{"key":"2254_CR87","doi-asserted-by":"publisher","first-page":"144099","DOI":"10.1016\/j.gene.2019.144099","volume":"720","author":"Y Wang","year":"2019","unstructured":"Wang Y, Li Y, He H, Wang F. Circular rna circ-prmt5 facilitates non-small cell lung cancer proliferation through upregulating ezh2 via sponging mir-377\/382\/498. Gene. 2019;720:144099. https:\/\/doi.org\/10.1016\/j.gene.2019.144099.","journal-title":"Gene"},{"issue":"10","key":"2254_CR88","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.tranon.2019.05.016","volume":"12","author":"Y Wang","year":"2019","unstructured":"Wang Y, Li J, Du C, Zhang L, Zhang Y, Zhang J, Wang L. Upregulated circular rna circ-ube2d2 predicts poor prognosis and promotes breast cancer progression by sponging mir-1236 and mir-1287. Transl Oncol. 2019;12(10):1305\u201313. https:\/\/doi.org\/10.1016\/j.tranon.2019.05.016.","journal-title":"Transl Oncol"},{"issue":"4","key":"2254_CR89","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.prp.2018.12.032","volume":"215","author":"L Wang","year":"2019","unstructured":"Wang L, Peng X, Lu X, Wei Q, Chen M, Liu L. Inhibition of hsa_circ_0001313 (circccdc66) induction enhances the radio-sensitivity of colon cancer cells via tumor suppressor mir-338-3p: effects of cicr_0001313 on colon cancer radio-sensitivity. Pathol Res Pract. 2019;215(4):689\u201396. https:\/\/doi.org\/10.1016\/j.prp.2018.12.032.","journal-title":"Pathol Res Pract"},{"issue":"10","key":"2254_CR90","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1038\/s41374-019-0273-2","volume":"99","author":"Z Wang","year":"2019","unstructured":"Wang Z, Ma K, Cheng Y, Abraham JM, Liu X, Ke X, Wang Z, Meltzer SJ. Synthetic circular multi-mir sponge simultaneously inhibits mir-21 and mir-93 in esophageal carcinoma. Lab Invest. 2019;99(10):1442\u201353. https:\/\/doi.org\/10.1038\/s41374-019-0273-2.","journal-title":"Lab Invest"},{"key":"2254_CR91","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.omtn.2020.07.027","volume":"21","author":"Y Huang","year":"2020","unstructured":"Huang Y, Dai Y, Wen C, He S, Shi J, Zhao D, Wu L, Zhou H. Circsetd3 contributes to acquired resistance to gefitinib in non-small-cell lung cancer by targeting the mir-520h\/abcg2 pathway. Mol Ther Nucleic Acids. 2020;21:885\u201399. https:\/\/doi.org\/10.1016\/j.omtn.2020.07.027.","journal-title":"Mol Ther Nucleic Acids."},{"issue":"1","key":"2254_CR92","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12943-020-01213-6","volume":"19","author":"X Huang","year":"2020","unstructured":"Huang X, Zhang P, Wei C, Peng R, Lu J, Gao C, Cai J, Yang X, Fan J, Ke A, et al. Circular rna circmet drives immunosuppression and anti-pd1 therapy resistance in hepatocellular carcinoma via the mir-30-5p\/snail\/dpp4 axis. Mol Cancer. 2020;19(1):92. https:\/\/doi.org\/10.1186\/s12943-020-01213-6.","journal-title":"Mol Cancer"},{"issue":"2","key":"2254_CR93","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.bbrc.2018.11.157","volume":"508","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Zheng X, Xu B, Chen L, Wang Q, Deng H, Jiang J. Circular rna hsa_circ_0004015 regulates the proliferation, invasion, and tki drug resistance of non-small cell lung cancer by mir-1183\/pdpk1 signaling pathway. Biochem Biophys Res Commun. 2019;508(2):527\u201335. https:\/\/doi.org\/10.1016\/j.bbrc.2018.11.157.","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"2254_CR94","doi-asserted-by":"publisher","first-page":"252","DOI":"10.21037\/atm-22-6346","volume":"11","author":"J Pan","year":"2023","unstructured":"Pan J, Xing J, Yu H, Wang Z, Wang W, Pan Y. Circrbm33 promotes migration, invasion and mediates osimertinib resistance in non-small cell lung cancer cell line. Ann Transl Med. 2023;11(6):252. https:\/\/doi.org\/10.21037\/atm-22-6346.","journal-title":"Ann Transl Med."},{"issue":"1","key":"2254_CR95","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12935-021-01764-8","volume":"21","author":"F Zhang","year":"2021","unstructured":"Zhang F, Cheng R, Li P, Lu C, Zhang G. Hsa_circ_0010235 functions as an oncogenic drive in non-small cell lung cancer by modulating mir-433-3p\/tiprl axis. Cancer Cell Int. 2021;21(1):73. https:\/\/doi.org\/10.1186\/s12935-021-01764-8.","journal-title":"Cancer Cell Int"},{"issue":"9","key":"2254_CR96","doi-asserted-by":"publisher","first-page":"3399","DOI":"10.26355\/eurrev_202105_25807","volume":"25","author":"S Zhang","year":"2021","unstructured":"Zhang S, Ma J, Wu J, Hao Z, Zhang Y, Zhang Y. Circular rna circcrim1 suppresses lung adenocarcinoma cell migration, invasion, emt, and glycolysis through regulating mir-125b-5p\/btg2 axis. Eur Rev Med Pharmacol Sci. 2021;25(9):3399. https:\/\/doi.org\/10.26355\/eurrev_202105_25807.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"2254_CR97","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1080\/21655979.2021.1872191","volume":"12","author":"C Zhang","year":"2021","unstructured":"Zhang C, Li Y, Feng X, Li D. Circular rna circ_0001287 inhibits the proliferation, metastasis, and radiosensitivity of non-small cell lung cancer cells by sponging microrna mir-21 and up-regulating phosphatase and tensin homolog expression. Bioengineered. 2021;12(1):414\u201325. https:\/\/doi.org\/10.1080\/21655979.2021.1872191.","journal-title":"Bioengineered"},{"issue":"9","key":"2254_CR98","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1080\/1061186X.2021.1906882","volume":"29","author":"H Zhang","year":"2021","unstructured":"Zhang H, Yan C, Wang Y. Exosome-mediated transfer of circhipk3 promotes trastuzumab chemoresistance in breast cancer. J Drug Target. 2021;29(9):1004\u201315. https:\/\/doi.org\/10.1080\/1061186X.2021.1906882.","journal-title":"J Drug Target"},{"issue":"4","key":"2254_CR99","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1080\/15548627.2019.1634945","volume":"16","author":"X Chen","year":"2020","unstructured":"Chen X, Mao R, Su W, Yang X, Geng Q, Guo C, Wang Z, Wang J, Kresty LA, Beer DG, et al. Circular rna circhipk3 modulates autophagy via mir124-3p-stat3-prkaa\/ampkalpha signaling in stk11 mutant lung cancer. Autophagy. 2020;16(4):659\u201371. https:\/\/doi.org\/10.1080\/15548627.2019.1634945.","journal-title":"Autophagy"},{"issue":"9","key":"2254_CR100","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1111\/1759-7714.13603","volume":"11","author":"Z Chen","year":"2020","unstructured":"Chen Z, Zhao H, Lin L, Liu J, Bai J, Wang G. Circular rna circhipk3 promotes cell proliferation and invasion of breast cancer by sponging mir-193a\/hmgb1\/pi3k\/akt axis. Thorac Cancer. 2020;11(9):2660\u201371. https:\/\/doi.org\/10.1111\/1759-7714.13603.","journal-title":"Thorac Cancer"},{"key":"2254_CR101","doi-asserted-by":"publisher","first-page":"5939","DOI":"10.2147\/OTT.S253468","volume":"13","author":"H Chen","year":"2020","unstructured":"Chen H, Pei L, Xie P, Guo G. Circ-prkdc contributes to 5-fluorouracil resistance of colorectal cancer cells by regulating mir-375\/foxm1 axis and wnt\/beta-catenin pathway. Onco Targets Ther. 2020;13:5939\u201353. https:\/\/doi.org\/10.2147\/OTT.S253468.","journal-title":"Onco Targets Ther"},{"issue":"7","key":"2254_CR102","first-page":"1566","volume":"7","author":"H Liang","year":"2017","unstructured":"Liang H, Zhang X, Liu B, Jia G, Li W. Circular rna circ-abcb10 promotes breast cancer proliferation and progression through sponging mir-1271. Am J Cancer Res. 2017;7(7):1566\u201376.","journal-title":"Am J Cancer Res"},{"key":"2254_CR103","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.2147\/CMAR.S238513","volume":"12","author":"W Yang","year":"2020","unstructured":"Yang W, Gong P, Yang Y, Yang C, Yang B, Ren L. Circ-abcb10 contributes to paclitaxel resistance in breast cancer through let-7a-5p\/dusp7 axis. Cancer Manag Res. 2020;12:2327\u201337. https:\/\/doi.org\/10.2147\/CMAR.S238513.","journal-title":"Cancer Manag Res."},{"issue":"19","key":"2254_CR104","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1111\/1759-7714.14928","volume":"14","author":"Z Kong","year":"2023","unstructured":"Kong Z, Han Q, Zhu B, Wan L, Feng E. Circ_0069094 regulates malignant phenotype and paclitaxel resistance in breast cancer cells via targeting the mir-136-5p\/ywhaz axis. Thorac Cancer. 2023;14(19):1831\u201342. https:\/\/doi.org\/10.1111\/1759-7714.14928.","journal-title":"Thorac Cancer"},{"issue":"1","key":"2254_CR105","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1620\/tjem.2023.J039","volume":"261","author":"J Liu","year":"2023","unstructured":"Liu J, Kong L, Bian W, Lin X, Wei F, Chu J. Circrna circabcb1 diminishes the sensitivity of breast cancer cells to docetaxel by sponging mir-153-3p. Tohoku J Exp Med. 2023;261(1):25\u201333. https:\/\/doi.org\/10.1620\/tjem.2023.J039.","journal-title":"Tohoku J Exp Med"},{"issue":"7","key":"2254_CR106","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1111\/1759-7714.13475","volume":"11","author":"H Zang","year":"2020","unstructured":"Zang H, Li Y, Zhang X, Huang G. Circ-rnf111 contributes to paclitaxel resistance in breast cancer by elevating e2f3 expression via mir-140-5p. Thorac Cancer. 2020;11(7):1891\u2013903. https:\/\/doi.org\/10.1111\/1759-7714.13475.","journal-title":"Thorac Cancer"},{"issue":"5","key":"2254_CR107","doi-asserted-by":"publisher","first-page":"3166","DOI":"10.1111\/jcmm.14171","volume":"23","author":"W Yang","year":"2019","unstructured":"Yang W, Gu J, Wang X, Wang Y, Feng M, Zhou D, Guo J, Zhou M. Inhibition of circular rna cdr1as increases chemosensitivity of 5-fu-resistant bc cells through up-regulating mir-7. J Cell Mol Med. 2019;23(5):3166\u201377. https:\/\/doi.org\/10.1111\/jcmm.14171.","journal-title":"J Cell Mol Med"},{"key":"2254_CR108","doi-asserted-by":"publisher","first-page":"6499","DOI":"10.2147\/CMAR.S203137","volume":"11","author":"G Yang","year":"2019","unstructured":"Yang G, Zhang T, Ye J, Yang J, Chen C, Cai S, Ma J. Circ-itga7 sponges mir-3187\u20133p to upregulate asxl1, suppressing colorectal cancer proliferation. Cancer Manag Res. 2019;11:6499\u2013509. https:\/\/doi.org\/10.2147\/CMAR.S203137.","journal-title":"Cancer Manag Res."},{"issue":"1","key":"2254_CR109","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12943-021-01332-8","volume":"20","author":"L Wang","year":"2021","unstructured":"Wang L, Zhou Y, Jiang L, Lu L, Dai T, Li A, Chen Y, Zhang L. Circwac induces chemotherapeutic resistance in triple-negative breast cancer by targeting mir-142, upregulating wwp1 and activating the pi3k\/akt pathway. Mol Cancer. 2021;20(1):43. https:\/\/doi.org\/10.1186\/s12943-021-01332-8.","journal-title":"Mol Cancer"},{"issue":"3","key":"2254_CR110","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/hon.2874","volume":"39","author":"D Wang","year":"2021","unstructured":"Wang D, Ming X, Xu J, Xiao Y. Circ_0009910 shuttled by exosomes regulates proliferation, cell cycle and apoptosis of acute myeloid leukemia cells by regulating mir-5195-3p\/grb10 axis. Hematol Oncol. 2021;39(3):390\u2013400. https:\/\/doi.org\/10.1002\/hon.2874.","journal-title":"Hematol Oncol"},{"key":"2254_CR111","doi-asserted-by":"publisher","first-page":"7487","DOI":"10.2147\/CMAR.S257441","volume":"12","author":"S Du","year":"2020","unstructured":"Du S, Zhang P, Ren W, Yang F, Du C. Circ-znf609 accelerates the radioresistance of prostate cancer cells by promoting the glycolytic metabolism through mir-501\u20133p\/hk2 axis. Cancer Manag Res. 2020;12:7487\u201399. https:\/\/doi.org\/10.2147\/CMAR.S257441.","journal-title":"Cancer Manag Res."},{"issue":"1","key":"2254_CR112","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12943-021-01476-7","volume":"21","author":"Y Ling","year":"2022","unstructured":"Ling Y, Liang G, Lin Q, Fang X, Luo Q, Cen Y, Mehrpour M, Hamai A, Liu Z, Shi Y, et al. Circcdyl2 promotes trastuzumab resistance via sustaining her2 downstream signaling in breast cancer. Mol Cancer. 2022;21(1):8. https:\/\/doi.org\/10.1186\/s12943-021-01476-7.","journal-title":"Mol Cancer"},{"issue":"3","key":"2254_CR113","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3233\/CBM-203252","volume":"31","author":"M Huang","year":"2021","unstructured":"Huang M, Li T, Wang Q, Li C, Zhou H, Deng S, Lv Z, He Y, Hou B, Zhu G. Silencing circpvt1 enhances radiosensitivity in non-small cell lung cancer by sponging microrna-1208. Cancer Biomark. 2021;31(3):263\u201379. https:\/\/doi.org\/10.3233\/CBM-203252.","journal-title":"Cancer Biomark"},{"issue":"6","key":"2254_CR114","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1007\/s12026-021-09237-w","volume":"69","author":"L Huang","year":"2021","unstructured":"Huang L, Ma J, Cui M. Circular rna hsa_circ_0001598 promotes programmed death-ligand-1-mediated immune escape and trastuzumab resistance via sponging mir-1184 in breast cancer cells. Immunol Res. 2021;69(6):558\u201367. https:\/\/doi.org\/10.1007\/s12026-021-09237-w.","journal-title":"Immunol Res"},{"issue":"5","key":"2254_CR115","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.4149\/neo_2022_220611N619","volume":"69","author":"X Guo","year":"2022","unstructured":"Guo X, Hua Y. Circular rnas: novel regulators of resistance to systemic treatments in breast cancer. Neoplasma. 2022;69(5):1019\u201328. https:\/\/doi.org\/10.4149\/neo_2022_220611N619.","journal-title":"Neoplasma"},{"issue":"13","key":"2254_CR116","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1038\/s41388-022-02232-x","volume":"41","author":"X Guo","year":"2022","unstructured":"Guo X, Liu T, Zhu W, Liu H, Zhang G, Song L, Zhao R, Chen X, Gao P. Circkdm4b suppresses breast cancer progression via the mir-675\/nedd4l axis. Oncogene. 2022;41(13):1895\u2013906. https:\/\/doi.org\/10.1038\/s41388-022-02232-x.","journal-title":"Oncogene"},{"issue":"4","key":"2254_CR117","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s13353-024-00840-9","volume":"65","author":"S Wang","year":"2024","unstructured":"Wang S, Li Q, Wang Y, Li X, Feng X, Wei Y, Wang J, Zhou X. Peptidylprolyl isomerase d circular rna sensitizes breast cancer to trastuzumab through remodeling her2 n4-acetylcytidine modification. J Appl Genet. 2024;65(4):797\u2013807. https:\/\/doi.org\/10.1007\/s13353-024-00840-9.","journal-title":"J Appl Genet"},{"issue":"34","key":"2254_CR118","doi-asserted-by":"publisher","first-page":"e2404628","DOI":"10.1002\/advs.202404628","volume":"11","author":"Z Wang","year":"2024","unstructured":"Wang Z, Li Y, Yang J, Sun Y, He Y, Wang Y, Liang Y, Chen X, Chen T, Han D, et al. Circcfl1 promotes tnbc stemness and immunoescape via deacetylation-mediated c-myc deubiquitylation to facilitate mutant tp53 transcription. Adv Sci (Weinh). 2024;11(34):e2404628. https:\/\/doi.org\/10.1002\/advs.202404628.","journal-title":"Adv Sci (Weinh)"},{"issue":"16_suppl","key":"2254_CR119","doi-asserted-by":"publisher","first-page":"e14569","DOI":"10.1200\/JCO.2024.42.16_suppl.e14569","volume":"42","author":"S Wang","year":"2024","unstructured":"Wang S, Yang J, Wei L, et al. An exhaustive pre-clinicalstudy of a circRNA drug candidate (cmRNA1210) encoding IL-12sc for anti-tumor therapeutics. J Clin Oncol. 2024;42(16_suppl):e14569\u2013e14569.","journal-title":"J Clin Oncol"},{"issue":"10","key":"2254_CR120","doi-asserted-by":"publisher","first-page":"e112408","DOI":"10.15252\/embj.2022112408","volume":"42","author":"J Yi","year":"2023","unstructured":"Yi J, Wang L, Hu G, Zhang Y, Du J, Ding J, Ji X, Shen H, Huang H, Ye F, et al. Circpvt1 promotes er-positive breast tumorigenesis and drug resistance by targeting esr1 and mavs. EMBO J. 2023;42(10):e112408. https:\/\/doi.org\/10.15252\/embj.2022112408.","journal-title":"EMBO J"},{"key":"2254_CR121","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.bbrc.2022.07.097","volume":"627","author":"J Liu","year":"2022","unstructured":"Liu J, Dai Z, Li M, Wang B, Zhang X, Li F, Zhang M, Zhang W. Circular rna circmet contributes to tamoxifen resistance of breast cancer cells by targeting mir-204\/ahr signaling. Biochem Biophys Res Commun. 2022;627:200\u20136. https:\/\/doi.org\/10.1016\/j.bbrc.2022.07.097.","journal-title":"Biochem Biophys Res Commun"},{"key":"2254_CR122","doi-asserted-by":"publisher","first-page":"100886","DOI":"10.1016\/j.drup.2022.100886","volume":"65","author":"Z Liu","year":"2022","unstructured":"Liu Z, Zheng N, Li J, Li C, Zheng D, Jiang X, Ge X, Liu M, Liu L, Song Z, et al. N6-methyladenosine-modified circular rna qsox1 promotes colorectal cancer resistance to anti-ctla-4 therapy through induction of intratumoral regulatory t cells. Drug Resist Updat. 2022;65:100886. https:\/\/doi.org\/10.1016\/j.drup.2022.100886.","journal-title":"Drug Resist Updat"},{"issue":"1","key":"2254_CR123","doi-asserted-by":"publisher","first-page":"e662","DOI":"10.1002\/ctm2.662","volume":"12","author":"D Liu","year":"2022","unstructured":"Liu D, Liu W, Chen X, Yin J, Ma L, Liu M, Zhou X, Xian L, Li P, Tan X, et al. Circkcnn2 suppresses the recurrence of hepatocellular carcinoma at least partially via regulating mir-520c-3p\/methyl-dna-binding domain protein 2 axis. Clin Transl Med. 2022;12(1):e662. https:\/\/doi.org\/10.1002\/ctm2.662.","journal-title":"Clin Transl Med"},{"issue":"12","key":"2254_CR124","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1111\/1440-1681.13702","volume":"49","author":"X Liang","year":"2022","unstructured":"Liang X, Liu X, Song Z, Zhu J, Zhang J. Hsa_circ_0097922 promotes tamoxifen resistance and cell malignant behaviour of breast cancer cells by regulating actn4 expression via mir-876-3p. Clin Exp Pharmacol Physiol. 2022;49(12):1257\u201369. https:\/\/doi.org\/10.1111\/1440-1681.13702.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"1","key":"2254_CR125","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12958-022-01011-3","volume":"20","author":"S Yang","year":"2022","unstructured":"Yang S, Zou C, Li Y, Yang X, Liu W, Zhang G, Lu N. Knockdown circtrim28 enhances tamoxifen sensitivity via the mir-409-3p\/hmga2 axis in breast cancer. Reprod Biol Endocrinol. 2022;20(1):146. https:\/\/doi.org\/10.1186\/s12958-022-01011-3.","journal-title":"Reprod Biol Endocrinol"},{"key":"2254_CR126","doi-asserted-by":"publisher","unstructured":"Yang J, Sun J, Zhu J, et al. Circular mRNA encoded PROTAC (RiboPROTAC) as a new platform for the degradation ofintracellular therapeutic targets. bioRxiv. 2022. Available from: https:\/\/doi.org\/10.1101\/2022.04.22.489232.","DOI":"10.1101\/2022.04.22.489232"},{"issue":"1","key":"2254_CR127","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12957-021-02149-x","volume":"19","author":"H Li","year":"2021","unstructured":"Li H, Li Q, He S. Hsa_circ_0025202 suppresses cell tumorigenesis and tamoxifen resistance via mir-197-3p\/hipk3 axis in breast cancer. World J Surg Oncol. 2021;19(1):39. https:\/\/doi.org\/10.1186\/s12957-021-02149-x.","journal-title":"World J Surg Oncol"},{"key":"2254_CR128","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.omtn.2020.08.037","volume":"23","author":"Y Li","year":"2021","unstructured":"Li Y, Zhang Y, Zhang S, Huang D, Li B, Liang G, Wu Y, Jiang Q, Li L, Lin C, et al. Circrna circarnt2 suppressed the sensitivity of hepatocellular carcinoma cells to cisplatin by targeting the mir-155\u20135p\/pdk1 axis. Mol Ther Nucleic Acids. 2021;23:244\u201354. https:\/\/doi.org\/10.1016\/j.omtn.2020.08.037.","journal-title":"Mol Ther Nucleic Acids."},{"key":"2254_CR129","doi-asserted-by":"publisher","unstructured":"Lin Y, Yu Y, Lin H, Hsiao K. Oxaliplatin-induced dhx9 phosphorylation promotes oncogenic circular rna ccdc66 expression and development of chemoresistance. Cancers (Basel). 2020;12(3). https:\/\/doi.org\/10.3390\/cancers12030697.","DOI":"10.3390\/cancers12030697"},{"key":"2254_CR130","doi-asserted-by":"publisher","first-page":"7723995","DOI":"10.1155\/2022\/7723995","volume":"2022","author":"Y Mo","year":"2022","unstructured":"Mo Y, Lu Q, Zhang Q, Chen J, Deng Y, Zhang K, Tao R, Liu W, Wang Y. Circular rna ccdc66 improves murine double minute 4 (mdm4) expression through targeting mir-370 in colorectal cancer. Comput Math Methods Med. 2022;2022:7723995. https:\/\/doi.org\/10.1155\/2022\/7723995.","journal-title":"Comput Math Methods Med"},{"issue":"1","key":"2254_CR131","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1186\/s12885-019-6028-z","volume":"19","author":"H Lu","year":"2019","unstructured":"Lu H, Yao B, Wen X, Jia B. Fbxw7 circular rna regulates proliferation, migration and invasion of colorectal carcinoma through nek2, mtor, and pten signaling pathways in vitro and in vivo. BMC Cancer. 2019;19(1):918. https:\/\/doi.org\/10.1186\/s12885-019-6028-z.","journal-title":"BMC Cancer"},{"issue":"1","key":"2254_CR132","doi-asserted-by":"publisher","first-page":"108","DOI":"10.4149\/neo_2020_200417N414","volume":"68","author":"Y Xu","year":"2021","unstructured":"Xu Y, Qiu A, Peng F, Tan X, Wang J, Gong X. Exosomal transfer of circular rna fbxw7 ameliorates the chemoresistance to oxaliplatin in colorectal cancer by sponging mir-18b-5p. Neoplasma. 2021;68(1):108\u201318. https:\/\/doi.org\/10.4149\/neo_2020_200417N414.","journal-title":"Neoplasma"},{"issue":"4","key":"2254_CR133","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.bbrc.2020.01.055","volume":"524","author":"Y Yan","year":"2020","unstructured":"Yan Y, Su M, Qin B. Circhipk3 promotes colorectal cancer cells proliferation and metastasis via modulating of mir-1207-5p\/fmnl2 signal. Biochem Biophys Res Commun. 2020;524(4):839\u201346. https:\/\/doi.org\/10.1016\/j.bbrc.2020.01.055.","journal-title":"Biochem Biophys Res Commun"},{"key":"2254_CR134","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.ebiom.2019.09.051","volume":"48","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Li C, Liu X, Wang Y, Zhao R, Yang Y, Zheng X, Zhang Y, Zhang X. Circhipk3 promotes oxaliplatin-resistance in colorectal cancer through autophagy by sponging mir-637. EBioMedicine. 2019;48:277\u201388. https:\/\/doi.org\/10.1016\/j.ebiom.2019.09.051.","journal-title":"EBioMedicine"},{"issue":"6","key":"2254_CR135","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1089\/cbr.2019.3389","volume":"36","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Zhong R, Deng C, Zhou Z. Circle rna circabcb10 modulates pfn2 to promote breast cancer progression, as well as aggravate radioresistance through facilitating glycolytic metabolism via mir-223-3p. Cancer Biother Radiopharm. 2021;36(6):477\u201390. https:\/\/doi.org\/10.1089\/cbr.2019.3389.","journal-title":"Cancer Biother Radiopharm"},{"key":"2254_CR136","doi-asserted-by":"publisher","unstructured":"Zhao K, Cheng X, Ye Z, Li Y, Peng W, Wu Y, Xing C. Exosome-mediated transfer of circ_0000338 enhances 5-fluorouracil resistance in colorectal cancer through regulating microrna 217 (mir-217) and mir-485\u20133p. Mol Cell Biol. 2021;41(5). https:\/\/doi.org\/10.1128\/MCB.00517-20.","DOI":"10.1128\/MCB.00517-20"},{"key":"2254_CR137","doi-asserted-by":"publisher","first-page":"101097","DOI":"10.1016\/j.drup.2024.101097","volume":"76","author":"J Lin","year":"2024","unstructured":"Lin J, Lyu Z, Feng H, Xie H, Peng J, Zhang W, Zheng J, Zheng J, Pan Z, Li Y. Circpdia3\/mir-449a\/xbp1 feedback loop curbs pyroptosis by inhibiting palmitoylation of the gsdme-c domain to induce chemoresistance of colorectal cancer. Drug Resist Updat. 2024;76:101097. https:\/\/doi.org\/10.1016\/j.drup.2024.101097.","journal-title":"Drug Resist Updat"},{"key":"2254_CR138","doi-asserted-by":"publisher","first-page":"101604","DOI":"10.1016\/j.tranon.2022.101604","volume":"28","author":"H Chen","year":"2023","unstructured":"Chen H, Zhang J, Yang L, Li Y, Wang Z, Ye C. Circ-zeb1 regulates epithelial-mesenchymal transition and chemotherapy resistance of colorectal cancer through acting on mir-200c-5p. Transl Oncol. 2023;28:101604. https:\/\/doi.org\/10.1016\/j.tranon.2022.101604.","journal-title":"Transl Oncol"},{"issue":"4","key":"2254_CR139","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/hepr.13870","volume":"53","author":"B Chen","year":"2023","unstructured":"Chen B, Li Q, Li Y, Li Q, Lai H, Huang S, Li C, Li Y. Circtmem181 upregulates arhgap29 to inhibit hepatocellular carcinoma migration and invasion by sponging mir-519a-5p. Hepatol Res. 2023;53(4):334\u201343. https:\/\/doi.org\/10.1111\/hepr.13870.","journal-title":"Hepatol Res"},{"issue":"1","key":"2254_CR140","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/s13577-022-00790-6","volume":"36","author":"Y Chen","year":"2023","unstructured":"Chen Y, Liu H, Zou J, Cao G, Li Y, Xing C, Wu J. Exosomal circ_0091741 promotes gastric cancer cell autophagy and chemoresistance via the mir-330-3p\/trim14\/dvl2\/wnt\/beta-catenin axis. Hum Cell. 2023;36(1):258\u201375. https:\/\/doi.org\/10.1007\/s13577-022-00790-6.","journal-title":"Hum Cell"},{"issue":"35","key":"2254_CR141","doi-asserted-by":"publisher","first-page":"e2204513","DOI":"10.1002\/advs.202204513","volume":"9","author":"Z Pan","year":"2022","unstructured":"Pan Z, Zheng J, Zhang J, Lin J, Lai J, Lyu Z, Feng H, Wang J, Wu D, Li Y. A novel protein encoded by exosomal circatg4b induces oxaliplatin resistance in colorectal cancer by promoting autophagy. Adv Sci (Weinh). 2022;9(35):e2204513. https:\/\/doi.org\/10.1002\/advs.202204513.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"2254_CR142","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12951-024-02331-9","volume":"22","author":"B Hui","year":"2024","unstructured":"Hui B, Zhou C, Xu Y, Wang R, Dong Y, Zhou Y, Ding J, Zhang X, Xu J, Gu Y. Exosomes secreted by fusobacterium nucleatum-infected colon cancer cells transmit resistance to oxaliplatin and 5-fu by delivering hsa_circ_0004085. J Nanobiotechnology. 2024;22(1):62. https:\/\/doi.org\/10.1186\/s12951-024-02331-9.","journal-title":"J Nanobiotechnology"},{"issue":"2","key":"2254_CR143","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41419-022-04561-x","volume":"13","author":"T Zhang","year":"2022","unstructured":"Zhang T, Wu D, Luo P, Liu T, Han R, Deng S, He M, Zhao Y, Xu Y. Circneil3 mediates pyroptosis to influence lung adenocarcinoma radiotherapy by upregulating pif1 through mir-1184 inhibition. Cell Death Dis. 2022;13(2):167. https:\/\/doi.org\/10.1038\/s41419-022-04561-x.","journal-title":"Cell Death Dis"},{"key":"2254_CR144","doi-asserted-by":"publisher","unstructured":"Zhang C, Wang J, Wang H, Li J. Circ-abcc1 enhances radioresistance of breast cancer cells via mir-627\u20135p\/abcc1 axis. Cell Mol Biol (Noisy-le-grand). 2022;68(10):187\u201392. https:\/\/doi.org\/10.14715\/cmb\/2022.68.10.29.","DOI":"10.14715\/cmb\/2022.68.10.29"},{"issue":"1","key":"2254_CR145","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s13105-021-00831-y","volume":"78","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Tan X, Lu Y. Exosomal transfer of circ_0006174 contributes to the chemoresistance of doxorubicin in colorectal cancer by depending on the mir-1205\/ccnd2 axis. J Physiol Biochem. 2022;78(1):39\u201350. https:\/\/doi.org\/10.1007\/s13105-021-00831-y.","journal-title":"J Physiol Biochem"},{"issue":"11","key":"2254_CR146","doi-asserted-by":"publisher","first-page":"e24741","DOI":"10.1002\/jcla.24741","volume":"36","author":"L Zhang","year":"2022","unstructured":"Zhang L, Xu T, Li Y, Pang Q, Ding X. Serum hsa_circ_0000615 is a prognostic biomarker of sorafenib resistance in hepatocellular carcinoma. J Clin Lab Anal. 2022;36(11):e24741. https:\/\/doi.org\/10.1002\/jcla.24741.","journal-title":"J Clin Lab Anal"},{"key":"2254_CR147","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.omtn.2021.12.001","volume":"27","author":"P Zhang","year":"2022","unstructured":"Zhang P, Sun H, Wen P, Wang Y, Cui Y, Wu J. Circrna circmed27 acts as a prognostic factor and mediator to promote lenvatinib resistance of hepatocellular carcinoma. Mol Ther Nucleic Acids. 2022;27:293\u2013303. https:\/\/doi.org\/10.1016\/j.omtn.2021.12.001.","journal-title":"Mol Ther Nucleic Acids."},{"issue":"1","key":"2254_CR148","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13062-024-00478-x","volume":"19","author":"Y Geng","year":"2024","unstructured":"Geng Y, Zheng X, Zhang D, Wei S, Feng J, Wang W, Zhang L, Wu C, Hu W. Circhif1a induces cetuximab resistance in colorectal cancer by promoting hif1alpha-mediated glycometabolism alteration. Biol Direct. 2024;19(1):36. https:\/\/doi.org\/10.1186\/s13062-024-00478-x.","journal-title":"Biol Direct"},{"issue":"1","key":"2254_CR149","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1186\/s13046-020-01799-1","volume":"39","author":"H Xu","year":"2020","unstructured":"Xu H, Liu Y, Cheng P, Wang C, Liu Y, Zhou W, Xu Y, Ji G. Circrna_0000392 promotes colorectal cancer progression through the mir-193a-5p\/pik3r3\/akt axis. J Exp Clin Cancer Res. 2020;39(1):283. https:\/\/doi.org\/10.1186\/s13046-020-01799-1.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"2254_CR150","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41392-020-00375-5","volume":"5","author":"J Xu","year":"2020","unstructured":"Xu J, Ji L, Liang Y, Wan Z, Zheng W, Song X, Gorshkov K, Sun Q, Lin H, Zheng X, et al. Circrna-sore mediates sorafenib resistance in hepatocellular carcinoma by stabilizing ybx1. Signal Transduct Target Ther. 2020;5(1):298. https:\/\/doi.org\/10.1038\/s41392-020-00375-5.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2254_CR151","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12943-020-01281-8","volume":"19","author":"J Xu","year":"2020","unstructured":"Xu J, Wan Z, Tang M, Lin Z, Jiang S, Ji L, Gorshkov K, Mao Q, Xia S, Cen D, et al. N(6)-methyladenosine-modified circrna-sore sustains sorafenib resistance in hepatocellular carcinoma by regulating beta-catenin signaling. Mol Cancer. 2020;19(1):163. https:\/\/doi.org\/10.1186\/s12943-020-01281-8.","journal-title":"Mol Cancer"},{"key":"2254_CR152","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.2147\/CMAR.S246272","volume":"12","author":"G Xu","year":"2020","unstructured":"Xu G, Li M, Wu J, Qin C, Tao Y, He H. Circular rna circnrip1 sponges microrna-138\u20135p to maintain hypoxia-induced resistance to 5-fluorouracil through hif-1alpha-dependent glucose metabolism in gastric carcinoma. Cancer Manag Res. 2020;12:2789\u2013802. https:\/\/doi.org\/10.2147\/CMAR.S246272.","journal-title":"Cancer Manag Res."},{"issue":"1","key":"2254_CR153","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12943-022-01531-x","volume":"21","author":"X Chong","year":"2022","unstructured":"Chong X, Chen J, Zheng N, Zhou Z, Hai Y, Chen S, Zhang Y, Yu Q, Yu S, Chen Z, et al. Pik3ca mutations-mediated downregulation of circlhfpl2 inhibits colorectal cancer progression via upregulating pten. Mol Cancer. 2022;21(1):118. https:\/\/doi.org\/10.1186\/s12943-022-01531-x.","journal-title":"Mol Cancer"},{"key":"2254_CR154","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41420-019-0202-6","volume":"5","author":"Y Luo","year":"2019","unstructured":"Luo Y, Fu Y, Huang R, Gao M, Liu F, Gui R, Nie X. Circrna_101505 sensitizes hepatocellular carcinoma cells to cisplatin by sponging mir-103 and promotes oxidored-nitro domain-containing protein 1 expression. Cell Death Discov. 2019;5:121. https:\/\/doi.org\/10.1038\/s41420-019-0202-6.","journal-title":"Cell Death Discov."},{"issue":"10","key":"2254_CR155","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1111\/1759-7714.15257","volume":"15","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Liu W, Huang T, Li J, Hu H, Xu X, Fan Z. Circcpa4 induces asct2 expression to promote tumor property of non-small cell lung cancer cells in a mir-145-5p-dependent manner. Thorac Cancer. 2024;15(10):764\u201377. https:\/\/doi.org\/10.1111\/1759-7714.15257.","journal-title":"Thorac Cancer"},{"issue":"7","key":"2254_CR156","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/s00262-024-03705-6","volume":"73","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Huo W, Li J. Circatad2 mitigates cd8(+) t cells antitumor immune surveillance in breast cancer via igf2bp3\/m(6)a\/pd-l1 manner. Cancer Immunol Immunother. 2024;73(7):130. https:\/\/doi.org\/10.1007\/s00262-024-03705-6.","journal-title":"Cancer Immunol Immunother"},{"issue":"6","key":"2254_CR157","doi-asserted-by":"publisher","first-page":"e18137","DOI":"10.1111\/jcmm.18137","volume":"28","author":"S Zhang","year":"2024","unstructured":"Zhang S, Ma J, Yu T, Song Z, Lau WY, Zha Y. Circ_hmgcs1 modulates hepatocellular carcinoma chemoresistance via mir-338-5p\/il-7 pathway. J Cell Mol Med. 2024;28(6):e18137. https:\/\/doi.org\/10.1111\/jcmm.18137.","journal-title":"J Cell Mol Med"},{"issue":"2","key":"2254_CR158","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/mc.23135","volume":"59","author":"Y Li","year":"2020","unstructured":"Li Y, Xu C, He C, Pu H, Liu J, Wang Y. Circmtdh.4\/mir-630\/aeg-1 axis participates in the regulation of proliferation, migration, invasion, chemoresistance, and radioresistance of nsclc. Mol Carcinog. 2020;59(2):141\u201353. https:\/\/doi.org\/10.1002\/mc.23135.","journal-title":"Mol Carcinog"},{"issue":"9","key":"2254_CR159","doi-asserted-by":"publisher","first-page":"5152","DOI":"10.1111\/jcmm.15162","volume":"24","author":"J Li","year":"2020","unstructured":"Li J, Qin X, Wu R, Wan L, Zhang L, Liu R. Circular rna circfbxo11 modulates hepatocellular carcinoma progress and oxaliplatin resistance through mir-605\/foxo3\/abcb1 axis. J Cell Mol Med. 2020;24(9):5152\u201361. https:\/\/doi.org\/10.1111\/jcmm.15162.","journal-title":"J Cell Mol Med"},{"key":"2254_CR160","doi-asserted-by":"publisher","first-page":"11701","DOI":"10.2147\/CMAR.S273826","volume":"12","author":"H Li","year":"2020","unstructured":"Li H, Zhi Y, Ma C, Shen Q, Sun F, Cai C. Circ_0062020 knockdown strengthens the radiosensitivity of prostate cancer cells. Cancer Manag Res. 2020;12:11701\u201312. https:\/\/doi.org\/10.2147\/CMAR.S273826.","journal-title":"Cancer Manag Res."},{"issue":"7","key":"2254_CR161","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1002\/cbin.11906","volume":"47","author":"X Yang","year":"2023","unstructured":"Yang X, Tian X, Zhao P, Wang Z, Sun X. Paclitaxel inhibits hepatocellular carcinoma tumorigenesis by regulating the circ_0005785\/mir-640\/gsk3beta. Cell Biol Int. 2023;47(7):1170\u201382. https:\/\/doi.org\/10.1002\/cbin.11906.","journal-title":"Cell Biol Int"},{"issue":"3","key":"2254_CR162","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.21037\/tlcr-21-230","volume":"10","author":"Y Dong","year":"2021","unstructured":"Dong Y, Qiu T, Xuan Y, Liu A, Sun X, Huang Z, Su W, Du W, Yun T, Wo Y, et al. Circfbxw7 attenuates malignant progression in lung adenocarcinoma by sponging mir-942\u20135p. Transl Lung Cancer Res. 2021;10(3):1457\u201373. https:\/\/doi.org\/10.21037\/tlcr-21-230.","journal-title":"Transl Lung Cancer Res."},{"issue":"1","key":"2254_CR163","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12943-021-01361-3","volume":"20","author":"Z Dong","year":"2021","unstructured":"Dong Z, Ke A, Li T, Cai J, Yang Y, Zhou W, Shi G, Fan J. Circmemo1 modulates the promoter methylation and expression of tcf21 to regulate hepatocellular carcinoma progression and sorafenib treatment sensitivity. Mol Cancer. 2021;20(1):75. https:\/\/doi.org\/10.1186\/s12943-021-01361-3.","journal-title":"Mol Cancer"},{"issue":"1","key":"2254_CR164","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/s12951-024-02582-6","volume":"22","author":"F Dong","year":"2024","unstructured":"Dong F, Xu Z, Wang Y, Li T, Wang X, Li J. Exosome-derived circupf2 enhances resistance to targeted therapy by redeploying ferroptosis sensitivity in hepatocellular carcinoma. J Nanobiotechnology. 2024;22(1):298. https:\/\/doi.org\/10.1186\/s12951-024-02582-6.","journal-title":"J Nanobiotechnology"},{"issue":"1","key":"2254_CR165","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1186\/s12967-024-05233-4","volume":"22","author":"J Gong","year":"2024","unstructured":"Gong J, Han G, Chen Z, Zhang Y, Xu B, Xu C, Gao W, Wu J. Circdcaf8 promotes the progression of hepatocellular carcinoma through mir-217\/nap1l1 axis, and induces angiogenesis and regorafenib resistance via exosome-mediated transfer. J Transl Med. 2024;22(1):517. https:\/\/doi.org\/10.1186\/s12967-024-05233-4.","journal-title":"J Transl Med"},{"issue":"1","key":"2254_CR166","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41420-022-00898-6","volume":"8","author":"L Chen","year":"2022","unstructured":"Chen L, Sun Y, Tang M, Wu D, Xiang Z, Huang C, You B, Xie D, Ye Q, Yu D, et al. High-dose-androgen-induced autophagic cell death to suppress the enzalutamide-resistant prostate cancer growth via altering the circrna-bcl2\/mirna-198\/ambra1 signaling. Cell Death Discov. 2022;8(1):128. https:\/\/doi.org\/10.1038\/s41420-022-00898-6.","journal-title":"Cell Death Discov"},{"issue":"1","key":"2254_CR167","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s13046-022-02404-3","volume":"41","author":"L Chen","year":"2022","unstructured":"Chen L, Song Y, Hou T, Li X, Cheng L, Li Y, Xing Y. Circ_0004087 interaction with snd1 promotes docetaxel resistance in prostate cancer by boosting the mitosis error correction mechanism. J Exp Clin Cancer Res. 2022;41(1):194. https:\/\/doi.org\/10.1186\/s13046-022-02404-3.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"2254_CR168","doi-asserted-by":"publisher","first-page":"153","DOI":"10.18388\/abp.2020_6379","volume":"70","author":"YY Chen","year":"2023","unstructured":"Chen YY, Luo LP, Deng KC. Circular rna lpar3 targets jpt1 via microrna-513b-5p to facilitate glycolytic activation but repress prostate cancer radiosensitivity. Acta Biochim Pol. 2023;70(1):153\u201362. https:\/\/doi.org\/10.18388\/abp.2020_6379.","journal-title":"Acta Biochim Pol"},{"issue":"2","key":"2254_CR169","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41419-018-1048-1","volume":"10","author":"G Wu","year":"2019","unstructured":"Wu G, Sun Y, Xiang Z, Wang K, Liu B, Xiao G, Niu Y, Wu D, Chang C. Preclinical study using circular rna 17 and micro rna 181c\u20135p to suppress the enzalutamide-resistant prostate cancer progression. Cell Death Dis. 2019;10(2):37. https:\/\/doi.org\/10.1038\/s41419-018-1048-1.","journal-title":"Cell Death Dis"},{"issue":"13","key":"2254_CR170","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.7150\/jca.86940","volume":"14","author":"Z Zhou","year":"2023","unstructured":"Zhou Z, Qin J, Song C, Wu T, Quan Q, Zhang Y, Zou Y, Liu L, Tang H, Zhao J. Circrobo1 promotes prostate cancer growth and enzalutamide resistance via accelerating glycolysis. J Cancer. 2023;14(13):2574\u201384. https:\/\/doi.org\/10.7150\/jca.86940.","journal-title":"J Cancer"},{"issue":"1","key":"2254_CR171","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1186\/s12967-022-03494-5","volume":"20","author":"F Gao","year":"2022","unstructured":"Gao F, Xu Q, Tang Z, Zhang N, Huang Y, Li Z, Dai Y, Yu Q, Zhu J. Exosomes derived from myeloid-derived suppressor cells facilitate castration-resistant prostate cancer progression via s100a9\/circmid1\/mir-506-3p\/mid1. J Transl Med. 2022;20(1):346. https:\/\/doi.org\/10.1186\/s12967-022-03494-5.","journal-title":"J Transl Med"},{"issue":"1","key":"2254_CR172","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s40364-022-00393-1","volume":"10","author":"H Yin","year":"2022","unstructured":"Yin H, Qin H, Yang L, Chen M, Yang Y, Zhang W, Hao J, Lu Q, Shi J, Zhuang J, et al. Circcyp24a1 promotes docetaxel resistance in prostate cancer by upregulating aldh1a3. Biomark Res. 2022;10(1):48. https:\/\/doi.org\/10.1186\/s40364-022-00393-1.","journal-title":"Biomark Res"},{"issue":"5","key":"2254_CR173","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1158\/0008-5472.CAN-21-2988","volume":"82","author":"X Jiang","year":"2022","unstructured":"Jiang X, Guo S, Wang S, Zhang Y, Chen H, Wang Y, Liu R, Niu Y, Xu Y. Eif4a3-induced circarhgap29 promotes aerobic glycolysis in docetaxel-resistant prostate cancer through igf2bp2\/c-myc\/ldha signaling. Cancer Res. 2022;82(5):831\u201345. https:\/\/doi.org\/10.1158\/0008-5472.CAN-21-2988.","journal-title":"Cancer Res"},{"key":"2254_CR174","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.canlet.2019.10.006","volume":"468","author":"Z Shen","year":"2020","unstructured":"Shen Z, Zhou L, Zhang C, Xu J. Reduction of circular rna foxo3 promotes prostate cancer progression and chemoresistance to docetaxel. Cancer Lett. 2020;468:88\u2013101. https:\/\/doi.org\/10.1016\/j.canlet.2019.10.006.","journal-title":"Cancer Lett"},{"issue":"9","key":"2254_CR175","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1097\/CAD.0000000000001365","volume":"33","author":"X Tan","year":"2022","unstructured":"Tan X, Song X, Fan B, Li M, Zhang A, Pei L. Exosomal circrna scm-like with four malignant brain tumor domains 2 (circ-sfmbt2) enhances the docetaxel resistance of prostate cancer via the microrna-136-5p\/tribbles homolog 1 pathway. Anticancer Drugs. 2022;33(9):871\u201382. https:\/\/doi.org\/10.1097\/CAD.0000000000001365.","journal-title":"Anticancer Drugs"},{"key":"2254_CR176","doi-asserted-by":"publisher","unstructured":"Peng W, Ye L, Xue Q, Wei X, Wang Z, Xiang X, Zhang S, Zhang P, Wang H, Zhou Q. Silencing of circcrim1 drives igf2bp1-mediated nsclc immune evasion. Cells. 2023;12(2). https:\/\/doi.org\/10.3390\/cells12020273.","DOI":"10.3390\/cells12020273"},{"issue":"1","key":"2254_CR177","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12943-020-01222-5","volume":"19","author":"P Zhang","year":"2020","unstructured":"Zhang P, Gao C, Huang X, Lu J, Guo X, Shi G, Cai J, Ke A. Cancer cell-derived exosomal circuhrf1 induces natural killer cell exhaustion and may cause resistance to anti-pd1 therapy in hepatocellular carcinoma. Mol Cancer. 2020;19(1):110. https:\/\/doi.org\/10.1186\/s12943-020-01222-5.","journal-title":"Mol Cancer"},{"issue":"3","key":"2254_CR178","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.bbrc.2020.03.156","volume":"526","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Miao Y, Fu Q, Hu H, Chen H, Zeng A, Jin Y, Jiang Y, Qian L, Wu L, et al. Circrnaccdc66 regulates cisplatin resistance in gastric cancer via the mir-618\/bcl2 axis. Biochem Biophys Res Commun. 2020;526(3):713\u201320. https:\/\/doi.org\/10.1016\/j.bbrc.2020.03.156.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"2254_CR179","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1089\/cbr.2020.3578","volume":"36","author":"W Yao","year":"2021","unstructured":"Yao W, Guo P, Mu Q, Wang Y. Exosome-derived circ-pvt1 contributes to cisplatin resistance by regulating autophagy, invasion, and apoptosis via mir-30a-5p\/yap1 axis in gastric cancer cells. Cancer Biother Radiopharm. 2021;36(4):347\u201359. https:\/\/doi.org\/10.1089\/cbr.2020.3578.","journal-title":"Cancer Biother Radiopharm"},{"key":"2254_CR180","doi-asserted-by":"publisher","unstructured":"Liu Y, Zhang L, Du W. Circular rna circ-pvt1 contributes to paclitaxel resistance of gastric cancer cells through the regulation of zeb1 expression by sponging mir-124-3p. Biosci Rep. 2019;39(12).\u00a0https:\/\/doi.org\/10.1042\/BSR20193045.","DOI":"10.1042\/BSR20193045"},{"key":"2254_CR181","doi-asserted-by":"publisher","first-page":"107206","DOI":"10.1016\/j.phrs.2024.107206","volume":"204","author":"X Chen","year":"2024","unstructured":"Chen X, Yang Y, Yu Y, Chen Z, Fan H, Zhang J, Zhu J. Circuggt2 downregulation by mettl14-dependent m(6)a modification suppresses gastric cancer progression and cisplatin resistance through interaction with mir-186\u20133p\/map3k9 axis. Pharmacol Res. 2024;204:107206. https:\/\/doi.org\/10.1016\/j.phrs.2024.107206.","journal-title":"Pharmacol Res"},{"issue":"1","key":"2254_CR182","doi-asserted-by":"publisher","first-page":"e708","DOI":"10.1002\/ctm2.708","volume":"12","author":"L Fang","year":"2022","unstructured":"Fang L, Lv J, Xuan Z, Li B, Li Z, He Z, Li F, Xu J, Wang S, Xia Y, et al. Circular cpm promotes chemoresistance of gastric cancer via activating prkaa2-mediated autophagy. Clin Transl Med. 2022;12(1):e708. https:\/\/doi.org\/10.1002\/ctm2.708.","journal-title":"Clin Transl Med"},{"issue":"10","key":"2254_CR183","doi-asserted-by":"publisher","first-page":"e23449","DOI":"10.1002\/jcla.23449","volume":"34","author":"X Lv","year":"2020","unstructured":"Lv X, Li P, Wang J, Gao H, Hei Y, Zhang J, Li S. Hsa_circ_0000520 influences herceptin resistance in gastric cancer cells through pi3k-akt signaling pathway. J Clin Lab Anal. 2020;34(10):e23449. https:\/\/doi.org\/10.1002\/jcla.23449.","journal-title":"J Clin Lab Anal"},{"issue":"4","key":"2254_CR184","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1093\/neuonc\/noaa214","volume":"23","author":"Y Wei","year":"2021","unstructured":"Wei Y, Lu C, Zhou P, Zhao L, Lyu X, Yin J, Shi Z, You Y. Eif4a3-induced circular rna asap1 promotes tumorigenesis and temozolomide resistance of glioblastoma via nras\/mek1\/erk1-2 signaling. Neuro Oncol. 2021;23(4):611\u201324. https:\/\/doi.org\/10.1093\/neuonc\/noaa214.","journal-title":"Neuro Oncol"},{"issue":"7","key":"2254_CR185","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1089\/cbr.2020.3575","volume":"36","author":"H Yin","year":"2021","unstructured":"Yin H, Cui X. Knockdown of circhipk3 facilitates temozolomide sensitivity in glioma by regulating cellular behaviors through mir-524-5p\/kif2a-mediated pi3k\/akt pathway. Cancer Biother Radiopharm. 2021;36(7):556\u201367. https:\/\/doi.org\/10.1089\/cbr.2020.3575.","journal-title":"Cancer Biother Radiopharm"},{"key":"2254_CR186","doi-asserted-by":"publisher","unstructured":"Hua L, Huang L, Zhang X, Feng H. Downregulation of hsa_circ_0000936 sensitizes resistant glioma cells to temozolomide by sponging mir-1294. J Biosci. 2020;45:101. https:\/\/doi.org\/10.1007\/s12038-020-00072-z.","DOI":"10.1007\/s12038-020-00072-z"},{"key":"2254_CR187","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.exphem.2018.10.011","volume":"70","author":"J Shang","year":"2019","unstructured":"Shang J, Chen W, Wang Z, Wei T, Chen Z, Wu W. Circpan3 mediates drug resistance in acute myeloid leukemia through the mir-153\u20135p\/mir-183\u20135p-xiap axis. Exp Hematol. 2019;70:42\u201354. https:\/\/doi.org\/10.1016\/j.exphem.2018.10.011.","journal-title":"Exp Hematol"},{"issue":"9","key":"2254_CR188","doi-asserted-by":"publisher","first-page":"e3329","DOI":"10.1002\/jgm.3329","volume":"23","author":"F Tian","year":"2021","unstructured":"Tian F, Chen Z, Zhu W, Tang M, Li J, Zhang X, Jiang J, Cheng X. Inhibition of hsa_circ_0003489 shifts balance from autophagy to apoptosis and sensitizes multiple myeloma cells to bortezomib via mir-874-3p\/hdac1 axis. J Gene Med. 2021;23(9):e3329. https:\/\/doi.org\/10.1002\/jgm.3329.","journal-title":"J Gene Med"},{"issue":"7","key":"2254_CR189","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1111\/1759-7714.14338","volume":"13","author":"J Zhao","year":"2022","unstructured":"Zhao J, Yan W, Huang W, Li Y. Circ_0010235 facilitates lung cancer development and immune escape by regulating mir-636\/pdl1 axis. Thorac Cancer. 2022;13(7):965\u201376. https:\/\/doi.org\/10.1111\/1759-7714.14338.","journal-title":"Thorac Cancer"},{"issue":"1","key":"2254_CR190","doi-asserted-by":"publisher","first-page":"15455","DOI":"10.1038\/s41598-021-94671-x","volume":"11","author":"T Katopodi","year":"2021","unstructured":"Katopodi T, Petanidis S, Domvri K, Zarogoulidis P, Anestakis D, Charalampidis C, Tsavlis D, Bai C, Huang H, Freitag L, et al. Kras-driven intratumoral heterogeneity triggers infiltration of m2 polarized macrophages via the circhipk3\/ptk2 immunosuppressive circuit. Sci Rep. 2021;11(1):15455. https:\/\/doi.org\/10.1038\/s41598-021-94671-x.","journal-title":"Sci Rep"},{"key":"2254_CR191","doi-asserted-by":"publisher","first-page":"595609","DOI":"10.3389\/fonc.2021.595609","volume":"11","author":"J Yang","year":"2021","unstructured":"Yang J, Jia Y, Wang B, Yang S, Du K, Luo Y, Li Y, Zhu B. Circular rna chst15 sponges mir-155\u20135p and mir-194\u20135p to promote the immune escape of lung cancer cells mediated by pd-l1. Front Oncol. 2021;11:595609. https:\/\/doi.org\/10.3389\/fonc.2021.595609.","journal-title":"Front Oncol"},{"issue":"22","key":"2254_CR192","doi-asserted-by":"publisher","first-page":"24560","DOI":"10.18632\/aging.203576","volume":"13","author":"W Ge","year":"2021","unstructured":"Ge W, Chi H, Tang H, Xu J, Wang J, Cai W, Ma H. Circular rna celf1 drives immunosuppression and anti-pd1 therapy resistance in non-small cell lung cancer via the mir-491\u20135p\/egfr axis. Aging (Albany NY). 2021;13(22):24560\u201379. https:\/\/doi.org\/10.18632\/aging.203576.","journal-title":"Aging (Albany NY)."},{"issue":"1","key":"2254_CR193","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s12935-022-02686-9","volume":"22","author":"Y Zheng","year":"2022","unstructured":"Zheng Y, Ren S, Zhang Y, Liu S, Meng L, Liu F, Gu L, Ai N, Sang M. Circular rna circwwc3 augments breast cancer progression through promoting m2 macrophage polarization and tumor immune escape via regulating the expression and secretion of il-4. Cancer Cell Int. 2022;22(1):264. https:\/\/doi.org\/10.1186\/s12935-022-02686-9.","journal-title":"Cancer Cell Int"},{"issue":"4","key":"2254_CR194","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s10616-023-00577-z","volume":"75","author":"L Fan","year":"2023","unstructured":"Fan L, Xu G, Zeng X. M2 macrophage-derived extracellular vesicles augment immune evasion and development of colorectal cancer via a circrna_ccdc66\/microrna-342-3p\/metadherin axis. Cytotechnology. 2023;75(4):293\u2013308. https:\/\/doi.org\/10.1007\/s10616-023-00577-z.","journal-title":"Cytotechnology"},{"key":"2254_CR195","doi-asserted-by":"publisher","first-page":"e380323","DOI":"10.1590\/acb380323","volume":"38","author":"F Ding","year":"2023","unstructured":"Ding F, Zhu J, Hu Y. Circular rna protein tyrosine kinase 2 aggravates pyroptosis and inflammation in septic lung tissue by promoting microrna-766\/eukaryotic initiation factor 5a axis-mediated atp efflux. Acta Cir Bras. 2023;38:e380323. https:\/\/doi.org\/10.1590\/acb380323.","journal-title":"Acta Cir Bras"},{"issue":"11","key":"2254_CR196","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1158\/1078-0432.CCR-22-3836","volume":"29","author":"N Ding","year":"2023","unstructured":"Ding N, You A, Yang H, Hu G, Lai C, Liu W, Ye F. A tumor-suppressive molecular axis ep300\/circrere\/mir-6837-3p\/mavs activates type i ifn pathway and antitumor immunity to suppress colorectal cancer. Clin Cancer Res. 2023;29(11):2095\u2013109. https:\/\/doi.org\/10.1158\/1078-0432.CCR-22-3836.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2254_CR197","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41467-024-44779-1","volume":"15","author":"C Zhou","year":"2024","unstructured":"Zhou C, Li W, Liang Z, Wu X, Cheng S, Peng J, Zeng K, Li W, Lan P, Yang X, et al. Mutant kras-activated circatxn7 fosters tumor immunoescape by sensitizing tumor-specific t cells to activation-induced cell death. Nat Commun. 2024;15(1):499. https:\/\/doi.org\/10.1038\/s41467-024-44779-1.","journal-title":"Nat Commun"},{"issue":"1","key":"2254_CR198","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12943-023-01759-1","volume":"22","author":"Z Hu","year":"2023","unstructured":"Hu Z, Chen G, Zhao Y, Gao H, Li L, Yin Y, Jiang J, Wang L, Mang Y, Gao Y, et al. Exosome-derived circccar1 promotes cd8 + t-cell dysfunction and anti-pd1 resistance in hepatocellular carcinoma. Mol Cancer. 2023;22(1):55. https:\/\/doi.org\/10.1186\/s12943-023-01759-1.","journal-title":"Mol Cancer"},{"issue":"2","key":"2254_CR199","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s10528-022-10273-w","volume":"61","author":"R Ye","year":"2023","unstructured":"Ye R, Lu X, Liu J, Duan Q, Xiao J, Duan X, Yue Z, Liu F. Circsod2 contributes to tumor progression, immune evasion and anti-pd-1 resistance in hepatocellular carcinoma by targeting mir-497-5p\/anxa11 axis. Biochem Genet. 2023;61(2):597\u2013614. https:\/\/doi.org\/10.1007\/s10528-022-10273-w.","journal-title":"Biochem Genet"},{"issue":"1","key":"2254_CR200","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12943-021-01475-8","volume":"20","author":"D Chen","year":"2021","unstructured":"Chen D, Sheng H, Zhang D, Jin Y, Zhao B, Chen N, Song K, Xu R. The circular rna circdlg1 promotes gastric cancer progression and anti-pd-1 resistance through the regulation of cxcl12 by sponging mir-141-3p. Mol Cancer. 2021;20(1):166. https:\/\/doi.org\/10.1186\/s12943-021-01475-8.","journal-title":"Mol Cancer"},{"key":"2254_CR201","doi-asserted-by":"publisher","first-page":"147733","DOI":"10.1016\/j.gene.2023.147733","volume":"887","author":"B Qu","year":"2023","unstructured":"Qu B, Liu J, Peng Z, Xiao Z, Li S, Wu J, Li S, Luo J. Circsod2 polarizes macrophages towards the m1 phenotype to alleviate cisplatin resistance in gastric cancer cells by targeting the mir-1296\/stat1 axis. Gene. 2023;887:147733. https:\/\/doi.org\/10.1016\/j.gene.2023.147733.","journal-title":"Gene"},{"issue":"1","key":"2254_CR202","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12943-020-01187-5","volume":"19","author":"M Ghetti","year":"2020","unstructured":"Ghetti M, Vannini I, Storlazzi CT, Martinelli G, Simonetti G. Linear and circular pvt1 in hematological malignancies and immune response: two faces of the same coin. Mol Cancer. 2020;19(1):69. https:\/\/doi.org\/10.1186\/s12943-020-01187-5.","journal-title":"Mol Cancer"},{"issue":"1","key":"2254_CR203","doi-asserted-by":"publisher","first-page":"96","DOI":"10.4149\/neo_2020_200331N333","volume":"68","author":"Y Jin","year":"2021","unstructured":"Jin Y, Su Z, Sheng H, Li K, Yang B, Li S. Circ_0086720 knockdown strengthens the radiosensitivity of non-small cell lung cancer via mediating the mir-375\/spin1 axis. Neoplasma. 2021;68(1):96\u2013107. https:\/\/doi.org\/10.4149\/neo_2020_200331N333.","journal-title":"Neoplasma"},{"issue":"1","key":"2254_CR204","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12935-023-02891-0","volume":"23","author":"K Lee","year":"2023","unstructured":"Lee K, Liu C, Chen L, Lee C, Lu T, Chuang L, Lai L. Hypoxia-responsive circular rna circaagab reduces breast cancer malignancy by activating p38 mapk and sponging mir-378 h. Cancer Cell Int. 2023;23(1):45. https:\/\/doi.org\/10.1186\/s12935-023-02891-0.","journal-title":"Cancer Cell Int"},{"issue":"5","key":"2254_CR205","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1159\/000495876","volume":"51","author":"X Li","year":"2018","unstructured":"Li X, Zhang Z, Jiang H, Li Q, Wang R, Pan H, Niu Y, Liu F, Gu H, Fan X, et al. Circular rna circpvt1 promotes proliferation and invasion through sponging mir-125b and activating e2f2 signaling in non-small cell lung cancer. Cell Physiol Biochem. 2018;51(5):2324\u201340. https:\/\/doi.org\/10.1159\/000495876.","journal-title":"Cell Physiol Biochem"},{"issue":"2","key":"2254_CR206","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/path.5125","volume":"246","author":"X Li","year":"2018","unstructured":"Li X, Wang J, Zhang C, Lin C, Zhang J, Zhang W, Zhang W, Lu Y, Zheng L, Li X. Circular rna circitga7 inhibits colorectal cancer growth and metastasis by modulating the ras pathway and upregulating transcription of its host gene itga7. J Pathol. 2018;246(2):166\u201379. https:\/\/doi.org\/10.1002\/path.5125.","journal-title":"J Pathol"},{"issue":"6","key":"2254_CR207","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1089\/cbr.2019.3538","volume":"37","author":"F Cai","year":"2022","unstructured":"Cai F, Li J, Zhang J, Huang S. Knockdown of circ_ccnb2 sensitizes prostate cancer to radiation through repressing autophagy by the mir-30b-5p\/kif18a axis. Cancer Biother Radiopharm. 2022;37(6):480\u201393. https:\/\/doi.org\/10.1089\/cbr.2019.3538.","journal-title":"Cancer Biother Radiopharm"},{"issue":"1","key":"2254_CR208","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/CAD.0000000000001361","volume":"34","author":"T Yu","year":"2023","unstructured":"Yu T, Du H, Sun C. Circ-abcc4 contributes to prostate cancer progression and radioresistance by mediating mir-1253\/sox4 cascade. Anticancer Drugs. 2023;34(1):155\u201365. https:\/\/doi.org\/10.1097\/CAD.0000000000001361.","journal-title":"Anticancer Drugs"},{"issue":"1","key":"2254_CR209","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13000-020-01056-1","volume":"15","author":"X Li","year":"2020","unstructured":"Li X, He J, Ren X, Zhao H, Zhao H. Circ_0003998 enhances doxorubicin resistance in hepatocellular carcinoma by regulating mir-218-5p\/eif5a2 pathway. Diagn Pathol. 2020;15(1):141. https:\/\/doi.org\/10.1186\/s13000-020-01056-1.","journal-title":"Diagn Pathol"},{"issue":"6","key":"2254_CR210","doi-asserted-by":"publisher","first-page":"689","DOI":"10.17219\/acem\/157063","volume":"32","author":"Y Cheng","year":"2023","unstructured":"Cheng Y. Hsa-circ-0000098 promotes the progression of hepatocellular carcinoma by regulation of mir-136\u20135p\/mmp2 axis. Adv Clin Exp Med. 2023;32(6):689\u2013700. https:\/\/doi.org\/10.17219\/acem\/157063.","journal-title":"Adv Clin Exp Med."},{"issue":"10299","key":"2254_CR211","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S0140-6736(21)00312-3","volume":"398","author":"AA Thai","year":"2021","unstructured":"Thai AA, Solomon BJ, Sequist LV, Gainor JF, Heist RS. Lung cancer. Lancet. 2021;398(10299):535\u201354. https:\/\/doi.org\/10.1016\/S0140-6736(21)00312-3.","journal-title":"Lancet"},{"key":"2254_CR212","doi-asserted-by":"publisher","first-page":"105309","DOI":"10.1016\/j.ebiom.2024.105309","volume":"107","author":"W Liu","year":"2024","unstructured":"Liu W, Sun Y, Huo Y, Zhang L, Zhang N, Yang M. Circular rnas in lung cancer: implications for preventing therapeutic resistance. EBioMedicine. 2024;107:105309. https:\/\/doi.org\/10.1016\/j.ebiom.2024.105309.","journal-title":"EBioMedicine."},{"issue":"1","key":"2254_CR213","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1515\/biol-2020-0070","volume":"15","author":"F Gu","year":"2020","unstructured":"Gu F, Zhang J, Yan L, Li D. Circhipk3\/mir-381-3p axis modulates proliferation, migration, and glycolysis of lung cancer cells by regulating the akt\/mtor signaling pathway. Open Life Sci. 2020;15(1):683\u201395. https:\/\/doi.org\/10.1515\/biol-2020-0070.","journal-title":"Open Life Sci"},{"issue":"3","key":"2254_CR214","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.bbrc.2018.10.087","volume":"506","author":"H Yu","year":"2018","unstructured":"Yu H, Chen Y, Jiang P. Circular rna hipk3 exerts oncogenic properties through suppression of mir-124 in lung cancer. Biochem Biophys Res Commun. 2018;506(3):455\u201362. https:\/\/doi.org\/10.1016\/j.bbrc.2018.10.087.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"2254_CR215","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1080\/15384047.2019.1669995","volume":"21","author":"H Lu","year":"2020","unstructured":"Lu H, Han X, Ren J, Ren K, Li Z, Sun Z. Circular rna hipk3 induces cell proliferation and inhibits apoptosis in non-small cell lung cancer through sponging mir-149. Cancer Biol Ther. 2020;21(2):113\u201321. https:\/\/doi.org\/10.1080\/15384047.2019.1669995.","journal-title":"Cancer Biol Ther"},{"issue":"2","key":"2254_CR216","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.advms.2023.10.003","volume":"68","author":"Y Zhu","year":"2023","unstructured":"Zhu Y, Shen L, Xia Q, Tao H, Liu Z, Wang M, Zhang X, Zhang J, Lv J. Extracellular vesicle-derived circhipk3: novel diagnostic biomarker for lung cancer. Adv Med Sci. 2023;68(2):426\u201332. https:\/\/doi.org\/10.1016\/j.advms.2023.10.003.","journal-title":"Adv Med Sci"},{"key":"2254_CR217","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.biopha.2018.12.007","volume":"111","author":"S Qin","year":"2019","unstructured":"Qin S, Zhao Y, Lim G, Lin H, Zhang X, Zhang X. Circular rna pvt1 acts as a competing endogenous rna for mir-497 in promoting non-small cell lung cancer progression. Biomed Pharmacother. 2019;111:244\u201350. https:\/\/doi.org\/10.1016\/j.biopha.2018.12.007.","journal-title":"Biomed Pharmacother"},{"key":"2254_CR218","doi-asserted-by":"publisher","unstructured":"Palcau AC, Canu V, Donzelli S, Strano S, Pulito C, Blandino G. Circpvt1: a pivotal circular node intersecting long non-coding-pvt1 and c-myc oncogenic signals. Mol Cancer. 2022;21(1). https:\/\/doi.org\/10.1186\/s12943-022-01514-y.","DOI":"10.1186\/s12943-022-01514-y"},{"issue":"1","key":"2254_CR219","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s13059-017-1368-y","volume":"18","author":"L Verduci","year":"2017","unstructured":"Verduci L, Ferraiuolo M, Sacconi A, Ganci F, Vitale J, Colombo T, Paci P, Strano S, Macino G, Rajewsky N, et al. The oncogenic role of circpvt1 in head and neck squamous cell carcinoma is mediated through the mutant p53\/yap\/tead transcription-competent complex. Genome Biol. 2017;18(1):237. https:\/\/doi.org\/10.1186\/s13059-017-1368-y.","journal-title":"Genome Biol"},{"issue":"24","key":"2254_CR220","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.1111\/1759-7714.14210","volume":"12","author":"W Tao","year":"2021","unstructured":"Tao W, Cao C, Ren G, Zhou D. Circular rna circcpa4 promotes tumorigenesis by regulating mir-214-3p\/tgif2 in lung cancer. Thorac Cancer. 2021;12(24):3356\u201369. https:\/\/doi.org\/10.1111\/1759-7714.14210.","journal-title":"Thorac Cancer"},{"issue":"9","key":"2254_CR221","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1111\/cas.14131","volume":"110","author":"L Wang","year":"2019","unstructured":"Wang L, Liang Y, Mao Q, Xia W, Chen B, Shen H, Xu L, Jiang F, Dong G. Circular rna circcrim1 inhibits invasion and metastasis in lung adenocarcinoma through the microrna (mir)-182\/mir-93-leukemia inhibitory factor receptor pathway. Cancer Sci. 2019;110(9):2960\u201372. https:\/\/doi.org\/10.1111\/cas.14131.","journal-title":"Cancer Sci"},{"issue":"4","key":"2254_CR222","doi-asserted-by":"publisher","first-page":"157","DOI":"10.32604\/or.2022.027547","volume":"30","author":"S Misir","year":"2022","unstructured":"Misir S, Yaman SO, Petrovic N, Sumer C, Hepokur C, Aliyazicioglu Y. Circrnas in drug resistance of breast cancer. Oncol Res. 2022;30(4):157\u201372. https:\/\/doi.org\/10.32604\/or.2022.027547.","journal-title":"Oncol Res"},{"key":"2254_CR223","doi-asserted-by":"publisher","first-page":"e54178","DOI":"10.2196\/54178","volume":"10","author":"A Trojan","year":"2024","unstructured":"Trojan A, Roth S, Atassi Z, Kiessling M, Zenhaeusern R, Kadvany Y, Schumacher J, Kullak-Ublick GA, Aapro M, Eniu A. JMIR Cancer. 2024;10:e54178. https:\/\/doi.org\/10.2196\/54178.","journal-title":"JMIR Cancer."},{"issue":"1","key":"2254_CR224","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s13046-018-0870-8","volume":"37","author":"X Wang","year":"2018","unstructured":"Wang X, Fang L. Advances in circular rnas and their roles in breast cancer. J Exp Clin Cancer Res. 2018;37(1):206. https:\/\/doi.org\/10.1186\/s13046-018-0870-8.","journal-title":"J Exp Clin Cancer Res"},{"issue":"91","key":"2254_CR225","doi-asserted-by":"publisher","first-page":"36252","DOI":"10.18632\/oncotarget.26363","volume":"9","author":"M Anurag","year":"2018","unstructured":"Anurag M, Ellis MJ, Haricharan S. Dna damage repair defects as a new class of endocrine treatment resistance driver. Oncotarget. 2018;9(91):36252\u20133. https:\/\/doi.org\/10.18632\/oncotarget.26363.","journal-title":"Oncotarget"},{"key":"2254_CR226","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.2147\/OTT.S299190","volume":"14","author":"L Qi","year":"2021","unstructured":"Qi L, Sun B, Yang B, Lu S. Circhipk3 (hsa_circ_0000284) promotes proliferation, migration and invasion of breast cancer cells via mir-326. Onco Targets Ther. 2021;14:3671\u201385. https:\/\/doi.org\/10.2147\/OTT.S299190.","journal-title":"Onco Targets Ther"},{"key":"2254_CR227","doi-asserted-by":"publisher","first-page":"e15572","DOI":"10.7717\/peerj.15572","volume":"11","author":"Q Lian","year":"2023","unstructured":"Lian Q, Song Y, Han L, Wang Z, Song Y. Development of a circhipk3-based cerna network and identification of mrna signature in breast cancer patients harboring brca mutation. PeerJ. 2023;11:e15572. https:\/\/doi.org\/10.7717\/peerj.15572.","journal-title":"PeerJ"},{"issue":"15","key":"2254_CR228","doi-asserted-by":"publisher","first-page":"3674","DOI":"10.7150\/jca.78090","volume":"13","author":"Z Wei","year":"2022","unstructured":"Wei Z, Shi Y, Xue C, Li M, Wei J, Li G, Xiong W, Zhou M. Understanding the dual roles of circhipk3 in tumorigenesis and tumor progression. J Cancer. 2022;13(15):3674\u201386. https:\/\/doi.org\/10.7150\/jca.78090.","journal-title":"J Cancer"},{"key":"2254_CR229","doi-asserted-by":"publisher","first-page":"5573","DOI":"10.2147\/CMAR.S307595","volume":"13","author":"J Ni","year":"2021","unstructured":"Ni J, Xi X, Xiao S, Xiao X. Silencing of circhipk3 sensitizes paclitaxel-resistant breast cancer cells to chemotherapy by regulating hk2 through targeting mir-1286. Cancer Manag Res. 2021;13:5573\u201385. https:\/\/doi.org\/10.2147\/CMAR.S307595.","journal-title":"Cancer Manag Res."},{"key":"2254_CR230","doi-asserted-by":"publisher","first-page":"110338","DOI":"10.1016\/j.cellsig.2022.110338","volume":"95","author":"P Shi","year":"2022","unstructured":"Shi P, Liu Y, Yang H, Hu B. Breast cancer derived exosomes promoted angiogenesis of endothelial cells in microenvironment via circhipk3\/mir-124\u20133p\/mtdh axis. Cell Signal. 2022;95:110338. https:\/\/doi.org\/10.1016\/j.cellsig.2022.110338.","journal-title":"Cell Signal"},{"key":"2254_CR231","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.cca.2021.03.010","volume":"518","author":"B Liu","year":"2021","unstructured":"Liu B, Zhao N, Zhou Y, Lu Y, Chen W, Huang Z, Wang D, Xu Y, Wai Ping Yam J, Cui Y. Circular rna circ_abcb10 in cancer. Clin Chim Acta. 2021;518:93\u2013100. https:\/\/doi.org\/10.1016\/j.cca.2021.03.010.","journal-title":"Clin Chim Acta"},{"key":"2254_CR232","doi-asserted-by":"publisher","first-page":"782938","DOI":"10.3389\/fcell.2022.782938","volume":"10","author":"Z Huang","year":"2022","unstructured":"Huang Z, Shan R, Wen W, Li J, Zeng X, Wan R. The emerging roles of circ-abcb10 in cancer. Front Cell Dev Biol. 2022;10:782938. https:\/\/doi.org\/10.3389\/fcell.2022.782938.","journal-title":"Front Cell Dev Biol."},{"issue":"1","key":"2254_CR233","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13058-023-01672-x","volume":"25","author":"W Xia","year":"2023","unstructured":"Xia W, Chen W, Ni C, Meng X, Wu J, Yang Q, Tang H, Yuan H, Fang S. Chemotherapy-induced exosomal circbach1 promotes breast cancer resistance and stemness via mir-217\/g3bp2 signaling pathway. Breast Cancer Res. 2023;25(1):85. https:\/\/doi.org\/10.1186\/s13058-023-01672-x.","journal-title":"Breast Cancer Res"},{"key":"2254_CR234","doi-asserted-by":"publisher","unstructured":"Wu Q, Siddharth S, Sharma D. Triple negative breast cancer: a mountain yet to be scaled despite the triumphs. Cancers (Basel). 2021;13(15). https:\/\/doi.org\/10.3390\/cancers13153697.","DOI":"10.3390\/cancers13153697"},{"issue":"Suppl 2","key":"2254_CR235","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1016\/j.breast.2015.07.008","volume":"24","author":"A Prat","year":"2015","unstructured":"Prat A, Pineda E, Adamo B, Galvan P, Fernandez A, Gaba L, Diez M, Viladot M, Arance A, Munoz M. Clinical implications of the intrinsic molecular subtypes of breast cancer. Breast. 2015;24(Suppl 2):S26-35. https:\/\/doi.org\/10.1016\/j.breast.2015.07.008.","journal-title":"Breast"},{"key":"2254_CR236","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1186\/s12935-020-01547-7","volume":"20","author":"D Dou","year":"2020","unstructured":"Dou D, Ren X, Han M, Xu X, Ge X, Gu Y, Wang X, Zhao S. Circube2d2 (hsa_circ_0005728) promotes cell proliferation, metastasis and chemoresistance in triple-negative breast cancer by regulating mir-512\u20133p\/cdca3 axis. Cancer Cell Int. 2020;20:454. https:\/\/doi.org\/10.1186\/s12935-020-01547-7.","journal-title":"Cancer Cell Int"},{"key":"2254_CR237","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/978-3-030-20301-6_10","volume":"1152","author":"A Ahmad","year":"2019","unstructured":"Ahmad A. Current updates on trastuzumab resistance in her2 overexpressing breast cancers. Adv Exp Med Biol. 2019;1152:217\u201328. https:\/\/doi.org\/10.1007\/978-3-030-20301-6_10.","journal-title":"Adv Exp Med Biol"},{"issue":"10087","key":"2254_CR238","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1016\/S0140-6736(16)32417-5","volume":"389","author":"S Loibl","year":"2017","unstructured":"Loibl S, Gianni L. Her2-positive breast cancer. Lancet. 2017;389(10087):2415\u201329. https:\/\/doi.org\/10.1016\/S0140-6736(16)32417-5.","journal-title":"Lancet"},{"issue":"5","key":"2254_CR239","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/s41416-020-0938-z","volume":"123","author":"I Mesa-Eguiagaray","year":"2020","unstructured":"Mesa-Eguiagaray I, Wild SH, Rosenberg PS, Bird SM, Brewster DH, Hall PS, Cameron DA, Morrison D, Figueroa JD. Distinct temporal trends in breast cancer incidence from 1997 to 2016 by molecular subtypes: a population-based study of scottish cancer registry data. Br J Cancer. 2020;123(5):852\u20139. https:\/\/doi.org\/10.1038\/s41416-020-0938-z.","journal-title":"Br J Cancer"},{"issue":"3","key":"2254_CR240","doi-asserted-by":"publisher","first-page":"e13129","DOI":"10.1111\/sji.13129","volume":"95","author":"G Zhulai","year":"2022","unstructured":"Zhulai G, Oleinik E. Targeting regulatory t cells in anti-pd-1\/pd-l1 cancer immunotherapy. Scand J Immunol. 2022;95(3):e13129. https:\/\/doi.org\/10.1111\/sji.13129.","journal-title":"Scand J Immunol"},{"issue":"8","key":"2254_CR241","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/s41568-024-00714-6","volume":"24","author":"MA Harris","year":"2024","unstructured":"Harris MA, Savas P, Virassamy B, O\u2019Malley MMR, Kay J, Mueller SN, Mackay LK, Salgado R, Loi S. Towards targeting the breast cancer immune microenvironment. Nat Rev Cancer. 2024;24(8):554\u201377. https:\/\/doi.org\/10.1038\/s41568-024-00714-6.","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"2254_CR242","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1200\/OP.21.00635","volume":"17","author":"C Shah","year":"2021","unstructured":"Shah C, Al-Hilli Z, Vicini F. Advances in breast cancer radiotherapy: implications for current and future practice. JCO Oncol Pract. 2021;17(12):697\u2013706. https:\/\/doi.org\/10.1200\/OP.21.00635.","journal-title":"JCO Oncol Pract"},{"issue":"23","key":"2254_CR243","doi-asserted-by":"publisher","first-page":"4139","DOI":"10.1002\/cncr.32163","volume":"125","author":"S Piawah","year":"2019","unstructured":"Piawah S, Venook AP. Targeted therapy for colorectal cancer metastases: a review of current methods of molecularly targeted therapy and the use of tumor biomarkers in the treatment of metastatic colorectal cancer. Cancer. 2019;125(23):4139\u201347. https:\/\/doi.org\/10.1002\/cncr.32163.","journal-title":"Cancer"},{"issue":"1","key":"2254_CR244","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1186\/s13046-019-1391-9","volume":"38","author":"J Wen","year":"2019","unstructured":"Wen J, Min X, Shen M, Hua Q, Han Y, Zhao L, Liu L, Huang G, Liu J, Zhao X. Acly facilitates colon cancer cell metastasis by ctnnb1. J Exp Clin Cancer Res. 2019;38(1):401. https:\/\/doi.org\/10.1186\/s13046-019-1391-9.","journal-title":"J Exp Clin Cancer Res"},{"issue":"9","key":"2254_CR245","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1158\/0008-5472.CAN-16-1883","volume":"77","author":"K Hsiao","year":"2017","unstructured":"Hsiao K, Lin Y, Gupta SK, Chang N, Yen L, Sun HS, Tsai S. Noncoding effects of circular rna ccdc66 promote colon cancer growth and metastasis. Cancer Res. 2017;77(9):2339\u201350. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-1883.","journal-title":"Cancer Res"},{"issue":"5","key":"2254_CR246","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1056\/NEJMra040958","volume":"352","author":"JA Meyerhardt","year":"2005","unstructured":"Meyerhardt JA, Mayer RJ. Systemic therapy for colorectal cancer. N Engl J Med. 2005;352(5):476\u201387. https:\/\/doi.org\/10.1056\/NEJMra040958.","journal-title":"N Engl J Med"},{"issue":"8","key":"2254_CR247","doi-asserted-by":"publisher","first-page":"875","DOI":"10.2217\/epi-2019-0042","volume":"11","author":"N Abu","year":"2019","unstructured":"Abu N, Hon KW, Jeyaraman S, Yahaya A, Abdullah NM, Mustangin M, Sulaiman SA, Jamal R, Ab-Mutalib N. Identification of differentially expressed circular rnas in chemoresistant colorectal cancer. Epigenomics. 2019;11(8):875\u201384. https:\/\/doi.org\/10.2217\/epi-2019-0042.","journal-title":"Epigenomics"},{"issue":"8","key":"2254_CR248","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nrm3838","volume":"15","author":"M Ha","year":"2014","unstructured":"Ha M, Kim VN. Regulation of microrna biogenesis. Nat Rev Mol Cell Biol. 2014;15(8):509\u201324. https:\/\/doi.org\/10.1038\/nrm3838.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"2254_CR249","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12885-023-11791-5","volume":"24","author":"C Yang","year":"2024","unstructured":"Yang C, Zhang Y, Yan M, Wang J, Wang J, Wang M, Xuan Y, Cheng H, Ma J, Chai C, et al. Exosomes derived from cancer-associated fibroblasts promote tumorigenesis, metastasis and chemoresistance of colorectal cancer by upregulating circ_0067557 to target lin28. BMC Cancer. 2024;24(1):64. https:\/\/doi.org\/10.1186\/s12885-023-11791-5.","journal-title":"BMC Cancer"},{"issue":"6","key":"2254_CR250","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.clinthera.2005.06.003","volume":"27","author":"S Wong","year":"2005","unstructured":"Wong S. Cetuximab: an epidermal growth factor receptor monoclonal antibody for the treatment of colorectal cancer. Clin Ther. 2005;27(6):684\u201394. https:\/\/doi.org\/10.1016\/j.clinthera.2005.06.003.","journal-title":"Clin Ther"},{"issue":"10","key":"2254_CR251","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1007\/s12325-018-0791-0","volume":"35","author":"G Fornasier","year":"2018","unstructured":"Fornasier G, Francescon S, Baldo P. An update of efficacy and safety of cetuximab in metastatic colorectal cancer: a narrative review. Adv Ther. 2018;35(10):1497\u2013509. https:\/\/doi.org\/10.1007\/s12325-018-0791-0.","journal-title":"Adv Ther"},{"issue":"10","key":"2254_CR252","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1016\/j.ejca.2012.02.057","volume":"48","author":"C Bokemeyer","year":"2012","unstructured":"Bokemeyer C, Van Cutsem E, Rougier P, Ciardiello F, Heeger S, Schlichting M, Celik I, Kohne C. Addition of cetuximab to chemotherapy as first-line treatment for kras wild-type metastatic colorectal cancer: pooled analysis of the crystal and opus randomised clinical trials. Eur J Cancer. 2012;48(10):1466\u201375. https:\/\/doi.org\/10.1016\/j.ejca.2012.02.057.","journal-title":"Eur J Cancer"},{"issue":"1","key":"2254_CR253","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s12029-021-00789-6","volume":"54","author":"A Gulmez","year":"2023","unstructured":"Gulmez A, Harputluoglu H. Advanced hepatocellular cancer treated with sorafenib and novel inflammatory markers. J Gastrointest Cancer. 2023;54(1):11\u20139. https:\/\/doi.org\/10.1007\/s12029-021-00789-6.","journal-title":"J Gastrointest Cancer"},{"key":"2254_CR254","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.csbj.2021.01.018","volume":"19","author":"X Tang","year":"2021","unstructured":"Tang X, Ren H, Guo M, Qian J, Yang Y, Gu C. Review on circular rnas and new insights into their roles in cancer. Comput Struct Biotechnol J. 2021;19:910\u201328. https:\/\/doi.org\/10.1016\/j.csbj.2021.01.018.","journal-title":"Comput Struct Biotechnol J"},{"issue":"1","key":"2254_CR255","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41392-020-0187-x","volume":"5","author":"W Tang","year":"2020","unstructured":"Tang W, Chen Z, Zhang W, Cheng Y, Zhang B, Wu F, Wang Q, Wang S, Rong D, Reiter FP, et al. The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects. Signal Transduct Target Ther. 2020;5(1):87. https:\/\/doi.org\/10.1038\/s41392-020-0187-x.","journal-title":"Signal Transduct Target Ther"},{"key":"2254_CR256","doi-asserted-by":"publisher","first-page":"1106665","DOI":"10.3389\/fgene.2023.1106665","volume":"14","author":"G Rao","year":"2023","unstructured":"Rao G, Peng X, Tian Y, Fu X, Zhang Y. Circular rnas in hepatocellular carcinoma: biogenesis, function, and pathology. Front Genet. 2023;14:1106665. https:\/\/doi.org\/10.3389\/fgene.2023.1106665.","journal-title":"Front Genet"},{"issue":"1","key":"2254_CR257","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1186\/s12967-023-04238-9","volume":"21","author":"Y Fang","year":"2023","unstructured":"Fang Y, Zhang X, Huang H, Zeng Z. The interplay between noncoding rnas and drug resistance in hepatocellular carcinoma: the big impact of little things. J Transl Med. 2023;21(1):369. https:\/\/doi.org\/10.1186\/s12967-023-04238-9.","journal-title":"J Transl Med"},{"issue":"6","key":"2254_CR258","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.7150\/thno.56174","volume":"11","author":"Z Rong","year":"2021","unstructured":"Rong Z, Xu J, Shi S, Tan Z, Meng Q, Hua J, Liu J, Zhang B, Wang W, Yu X, et al. Circular rna in pancreatic cancer: a novel avenue for the roles of diagnosis and treatment. Theranostics. 2021;11(6):2755\u201369. https:\/\/doi.org\/10.7150\/thno.56174.","journal-title":"Theranostics"},{"issue":"6","key":"2254_CR259","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/s41419-021-03854-x","volume":"12","author":"L Ding","year":"2021","unstructured":"Ding L, Wang R, Shen D, Cheng S, Wang H, Lu Z, Zheng Q, Wang L, Xia L, Li G. Role of noncoding rna in drug resistance of prostate cancer. Cell Death Dis. 2021;12(6):590. https:\/\/doi.org\/10.1038\/s41419-021-03854-x.","journal-title":"Cell Death Dis"},{"issue":"6","key":"2254_CR260","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/nrclinonc.2014.68","volume":"11","author":"AJ Chang","year":"2014","unstructured":"Chang AJ, Autio KA, Roach MR, Scher HI. High-risk prostate cancer-classification and therapy. Nat Rev Clin Oncol. 2014;11(6):308\u201323. https:\/\/doi.org\/10.1038\/nrclinonc.2014.68.","journal-title":"Nat Rev Clin Oncol"},{"key":"2254_CR261","doi-asserted-by":"publisher","first-page":"216247","DOI":"10.1016\/j.canlet.2023.216247","volume":"566","author":"K Gao","year":"2023","unstructured":"Gao K, Li X, Ni J, Wu B, Guo J, Zhang R, Wu G. Non-coding rnas in enzalutamide resistance of castration-resistant prostate cancer. Cancer Lett. 2023;566:216247. https:\/\/doi.org\/10.1016\/j.canlet.2023.216247.","journal-title":"Cancer Lett"},{"issue":"1","key":"2254_CR262","doi-asserted-by":"publisher","first-page":"10739","DOI":"10.1038\/s41598-019-47189-2","volume":"9","author":"J Greene","year":"2019","unstructured":"Greene J, Baird A, Casey O, Brady L, Blackshields G, Lim M, O\u2019Brien O, Gray SG, Mcdermott R, Finn SP. Circular rnas are differentially expressed in prostate cancer and are potentially associated with resistance to enzalutamide. Sci Rep. 2019;9(1):10739. https:\/\/doi.org\/10.1038\/s41598-019-47189-2.","journal-title":"Sci Rep"},{"issue":"5","key":"2254_CR263","doi-asserted-by":"publisher","first-page":"166045","DOI":"10.1016\/j.bbadis.2020.166045","volume":"1867","author":"R Drula","year":"2021","unstructured":"Drula R, Pirlog R, Trif M, Slaby O, Braicu C, Berindan-Neagoe I. Circfoxo3: going around the mechanistic networks in cancer by interfering with mirnas regulatory networks. Biochim Biophys Acta Mol Basis Dis. 2021;1867(5):166045. https:\/\/doi.org\/10.1016\/j.bbadis.2020.166045.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"1","key":"2254_CR264","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12943-020-01185-7","volume":"19","author":"L Wei","year":"2020","unstructured":"Wei L, Sun J, Zhang N, Zheng Y, Wang X, Lv L, Liu J, Xu Y, Shen Y, Yang M. Noncoding rnas in gastric cancer: implications for drug resistance. Mol Cancer. 2020;19(1):62. https:\/\/doi.org\/10.1186\/s12943-020-01185-7.","journal-title":"Mol Cancer"},{"issue":"3","key":"2254_CR265","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1097\/SLA.0000000000002116","volume":"267","author":"Y Jiang","year":"2018","unstructured":"Jiang Y, Zhang Q, Hu Y, Li T, Yu J, Zhao L, Ye G, Deng H, Mou T, Cai S, et al. Immunoscore signature: a prognostic and predictive tool in gastric cancer. Ann Surg. 2018;267(3):504\u201313. https:\/\/doi.org\/10.1097\/SLA.0000000000002116.","journal-title":"Ann Surg"},{"issue":"1","key":"2254_CR266","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12943-020-01270-x","volume":"19","author":"L Peng","year":"2020","unstructured":"Peng L, Sang H, Wei S, Li Y, Jin D, Zhu X, Li X, Dang Y, Zhang G. Circcul2 regulates gastric cancer malignant transformation and cisplatin resistance by modulating autophagy activation via mir-142-3p\/rock2. Mol Cancer. 2020;19(1):156. https:\/\/doi.org\/10.1186\/s12943-020-01270-x.","journal-title":"Mol Cancer"},{"issue":"11","key":"2254_CR267","doi-asserted-by":"publisher","first-page":"5927","DOI":"10.21873\/anticanres.13797","volume":"39","author":"S Nakata","year":"2019","unstructured":"Nakata S, Fujita M, Nakanishi H. Efficacy of afatinib and lapatinib against her2 gene-amplified trastuzumab-sensitive and -resistant human gastric cancer cells. Anticancer Res. 2019;39(11):5927\u201332. https:\/\/doi.org\/10.21873\/anticanres.13797.","journal-title":"Anticancer Res"},{"key":"2254_CR268","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2147\/TACG.S365613","volume":"15","author":"SI Tayel","year":"2022","unstructured":"Tayel SI, Soliman SE, Ahmedy IA, Abdelhafez M, Elkholy AM, Hegazy A, Muharram NM. Deregulation of circanxa2, circ0075001, and circfbxw7 gene expressions and their predictive value in egyptian acute myeloid leukemia patients. Appl Clin Genet. 2022;15:69\u201385. https:\/\/doi.org\/10.2147\/TACG.S365613.","journal-title":"Appl Clin Genet"},{"issue":"9","key":"2254_CR269","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41568-024-00721-7","volume":"24","author":"VM Conn","year":"2024","unstructured":"Conn VM, Chinnaiyan AM, Conn SJ. Circular rna in cancer. Nat Rev Cancer. 2024;24(9):597\u2013613. https:\/\/doi.org\/10.1038\/s41568-024-00721-7.","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"2254_CR270","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/cr.2015.82","volume":"25","author":"Y Li","year":"2015","unstructured":"Li Y, Zheng Q, Bao C, Li S, Guo W, Zhao J, Chen D, Gu J, He X, Huang S. Circular rna is enriched and stable in exosomes: a promising biomarker for cancer diagnosis. Cell Res. 2015;25(8):981\u20134. https:\/\/doi.org\/10.1038\/cr.2015.82.","journal-title":"Cell Res"},{"issue":"4","key":"2254_CR271","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.cell.2018.12.021","volume":"176","author":"JN Vo","year":"2019","unstructured":"Vo JN, Cieslik M, Zhang Y, Shukla S, Xiao L, Zhang Y, Wu Y, Dhanasekaran SM, Engelke CG, Cao X, et al. The landscape of circular rna in cancer. Cell. 2019;176(4):869\u201381. https:\/\/doi.org\/10.1016\/j.cell.2018.12.021.","journal-title":"Cell"},{"issue":"11","key":"2254_CR272","doi-asserted-by":"publisher","first-page":"e720","DOI":"10.1002\/mco2.720","volume":"5","author":"J Cai","year":"2024","unstructured":"Cai J, Qiu Z, Chi-Shing Cho W, Liu Z, Chen S, Li H, Chen K, Li Y, Zuo C, Qiu M. Synthetic circrna therapeutics: innovations, strategies, and future horizons. MedComm (2020). 2024;5(11):e720. https:\/\/doi.org\/10.1002\/mco2.720.","journal-title":"MedComm (2020)"},{"key":"2254_CR273","doi-asserted-by":"publisher","first-page":"8057","DOI":"10.1038\/srep08057","volume":"5","author":"A Bachmayr-Heyda","year":"2015","unstructured":"Bachmayr-Heyda A, Reiner AT, Auer K, Sukhbaatar N, Aust S, Bachleitner-Hofmann T, Mesteri I, Grunt TW, Zeillinger R, Pils D. Correlation of circular rna abundance with proliferation\u2013exemplified with colorectal and ovarian cancer, idiopathic lung fibrosis, and normal human tissues. Sci Rep. 2015;5:8057. https:\/\/doi.org\/10.1038\/srep08057.","journal-title":"Sci Rep"},{"issue":"27","key":"2254_CR274","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Perez Marc G, Moreira ED, Zerbini C, et al. Safety and efficacy of the bnt162b2 mrna covid-19 vaccine. N Engl J Med. 2020;383(27):2603\u201315. https:\/\/doi.org\/10.1056\/NEJMoa2034577.","journal-title":"N Engl J Med"},{"key":"2254_CR275","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.omtn.2018.09.010","volume":"13","author":"X Liu","year":"2018","unstructured":"Liu X, Abraham JM, Cheng Y, Wang Z, Wang Z, Zhang G, Ashktorab H, Smoot DT, Cole RN, Boronina TN, et al. Synthetic circular rna functions as a mir-21 sponge to suppress gastric carcinoma cell proliferation. Mol Ther Nucleic Acids. 2018;13:312\u201321. https:\/\/doi.org\/10.1016\/j.omtn.2018.09.010.","journal-title":"Mol Ther Nucleic Acids."},{"issue":"1","key":"2254_CR276","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1186\/s12964-024-01995-y","volume":"22","author":"NMF Abdalsalam","year":"2024","unstructured":"Abdalsalam NMF, Ibrahim A, Saliu MA, Liu T, Wan X, Yan D. Mdsc: a new potential breakthrough in car-t therapy for solid tumors. Cell Commun Signal. 2024;22(1):612. https:\/\/doi.org\/10.1186\/s12964-024-01995-y.","journal-title":"Cell Commun Signal"},{"key":"2254_CR277","doi-asserted-by":"publisher","first-page":"809754","DOI":"10.3389\/fonc.2022.809754","volume":"12","author":"T Xin","year":"2022","unstructured":"Xin T, Cheng L, Zhou C, Zhao Y, Hu Z, Wu X. In-vivo induced car-t cell for the potential breakthrough to overcome the barriers of current car-t cell therapy. Front Oncol. 2022;12:809754. https:\/\/doi.org\/10.3389\/fonc.2022.809754.","journal-title":"Front Oncol"},{"issue":"29","key":"2254_CR278","doi-asserted-by":"publisher","first-page":"e2400307","DOI":"10.1002\/adma.202400307","volume":"36","author":"S Xu","year":"2024","unstructured":"Xu S, Xu Y, Solek NC, Chen J, Gong F, Varley AJ, Golubovic A, Pan A, Dong S, Zheng G, et al. Tumor-tailored ionizable lipid nanoparticles facilitate il-12 circular rna delivery for enhanced lung cancer immunotherapy. Adv Mater. 2024;36(29):e2400307. https:\/\/doi.org\/10.1002\/adma.202400307.","journal-title":"Adv Mater"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02254-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-025-02254-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02254-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T22:21:03Z","timestamp":1740435663000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-025-02254-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,25]]},"references-count":278,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2254"],"URL":"https:\/\/doi.org\/10.1186\/s12943-025-02254-5","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,25]]},"assertion":[{"value":"6 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"55"}}